Document:

Master Loan and Security Agreement

 Exhibit 10.49 

ATEL VENTURES, INC. 

MASTER LOAN AND SECURITY AGREEMENT NO. AMYRX 

Dated as of JUNE 1, 2010 
  

					
	 Between

	    	 ATEL VENTURES, INC., a California

corporation, as Lender (“Lender”)
	    	 600 California Street, 6th
Floor
 San Francisco CA 94108-2733

Attention: General Counsel

Tel: (415) 989-8800 Fax: (415) 989-3796

Email: avi@atel.com

			
	 And 
	    	 AMYRIS BIOTECHNOLOGIES, INC., a

Delaware corporation, as Borrower (“Borrower”)
	    	 5885 Hollis Street, Suite #100

Emeryville, CA 94608

Attention: Mr. Thomas Krivas, Vice President/Risk Management 

TEL: (510) 597-4857 FAX: (510) 225-2645 

EMAIL: krivast@amyris.com

NO INTEREST IN THE LOAN PAYMENT DUE OR THE RIGHTS OF THE LENDER UNDER ANY LOAN CAN BE TRANSFERRED BY THE DELIVERY OF POSSESSION OF ANY
COUNTERPART OF THIS MASTER LOAN AND SECURITY AGREEMENT. SUCH AN INTEREST CAN BE TRANSFERRED ONLY BY DELIVERY OF POSSESSION OF THE ORIGINAL SIGNED COUNTERPART OF A LOAN SCHEDULE EXECUTED PURSUANT HERETO. 

The parties of this Master Loan and Security Agreement (“Loan Agreement”) hereto agree as follows: 

 
  

 

	1.	 Loan: 

Lender agrees to loan to Borrower, and Borrower agrees to borrow from Lender, subject to satisfaction of the conditions
set forth in Section 3 and any Loan Schedule, funds for the financing of Borrower’s personal property described in any Loan Schedule (in each case, the “Collateral”). Any reference herein to a “Loan” shall mean any Loan
Schedule, as it incorporates by reference all the terms and conditions of this Loan Agreement, the Requests for Advances, and any Exhibits, Riders, Supplements, amendments, or addendum thereto, if any, and such Loan Schedule, as it incorporates the
terms and conditions of the Loan Agreement, is a separate and independent Loan. 
  

	2.	 Definitions: 

(a)         “Acceptance Date” means the date upon which Lender shall
have granted Borrower an Advance pursuant to Section 3(c) hereof, as indicated on the applicable Request for Advance. 

(b)        “Advance” means the Collateral Cost under any Request for
Advance or Loan Schedule which is funded by the Lender. 

(c)        “Advance Date” means the date of any Advance as set forth
on the applicable Request for Advance, which is made by Lender to Borrower or any Vendor as requested pursuant to any Request for Advance. 

(d)        “Assignee” has the meaning ascribed thereto in
Section 11 hereof. 
 (e)        “Balance Due Value”
means the product of the corresponding percentage indicated on the Rider to the applicable Loan Schedule, for the Loan Payment date immediately preceding the date that the event which caused the Event of Loss or Event of Default occurred times the
Collateral Cost of the item of Collateral suffering the Event of Loss (or of all Collateral in the event of an Event of Default). 

(f)        “Basic Loan Payment” means the amount indicated as the
Basic Loan Payment, due monthly in advance or in arrears, as set forth in the applicable Request for Advance and Loan Schedule. 

(g)        “Basic Loan Term” means the initial term of any Loan, as
indicated on the applicable Loan Schedule. 

(h)        “Borrower Reports” means any financial statements,
projections, budget, business plan, private placement memorandum, due diligence materials, prospectus, registration statements, or any other

 
materials prepared by Borrower and distributed to its investors, creditors, or Lender. 

(i)        “Change in Control” means a change in the majority
interest or control of ownership of the Borrower in any one transaction or series of related transactions, or a sale, assignment, or acquisition of all, or substantially all, of the property of Borrower by merger, consolidation or purchase
(excluding new amounts of equity securities which shall not be counted) and, provided further, this definition shall not apply to any acquisition of Borrower by means of merger, reverse merger, consolidation or otherwise if Lender has been notified
in writing at least ten (10) days prior to any such event and Lender has determined in its reasonable discretion that the acquiring entity immediately after such acquisition has a net worth at least equal to 125% of Borrower’s net worth
measured immediately prior to such acquisition (“Permitted Transaction”). 

(j)        “Collateral” means any lab equipment, manufacturing
equipment, computer hardware such as PCs, servers, networking equipment, software, test equipment, telecom equipment, furniture and office equipment and includes Current Collateral and Soft Collateral which was purchased with funds loaned to
Borrower under this Loan Agreement. 
 (k)        “Collateral
Cost” means the cost of the Collateral (including Soft Collateral) described in any Loan Schedule. 

(l)        “Commencement Date” means the first day of the calendar
month following the Advance Date, as is indicated in the applicable Loan Schedule. 

(m)        “Current Collateral” means the cost of the Collateral
(including Soft Collateral) described in any Loan Schedule. 

(n)        “Daily Loan Payment” means the daily equivalent of the
Basic Loan Payment which shall be due from the Advance Date to but excluding the Commencement Date during the Supplemental Loan Term. 

(o)        “Event of Default” means as defined in Section 9(a)
hereof. 
 (p)        “Event of Loss” means as defined in
Section 8(a) hereof. 
 (q)        “Final Payment”
means the final payment due by Borrower hereunder, whether as Basic Loan Payment, balloon payment or other fixed payment, as provided in Section 14 hereof. 

(r)        “Guarantor” means a guarantor or surety of the obligations
of the Borrower hereunder, if any. 

  

 Page 1 of 8 

 (s)        “Loan
Payment” means Basic Loan Payment or Daily Loan Payment. 

(t)        “Loan Schedule” means a Loan Schedule substantially in the
form of Exhibit A hereto, executed pursuant to this Loan Agreement and “Loan Schedules” means all such Loan Schedules. 

(u)        “Loan Term” means the Basic Loan Term and any Supplemental
Loan Term. 
 (v)        “Proposal Letter” means any letter
issued by Lender to Borrower describing the basic terms of a proposed loan financing. To the extent there is a conflict between the Proposal letter and this Loan, the terms and conditions of this Loan shall govern. 

(w)        “Purchase Agreement” means the contract for sale entered
into by the Borrower and the Vendor, and shall include any and all purchase orders, purchase agreements, invoices, and amendments to any of them. 

(x)        “Request for Advance” means the Request for Advance in the
form of Exhibit B hereto. 
 (y)        “Soft
Collateral” means certain custom use collateral, intangible personal property, warranty, service or other contract rights, taxes paid or prepaid, and other items generally considered fungible or expendable. 

(z)        “Supplemental Loan Term” means the period from the Advance
Date to the Commencement Date. 
 (aa)        “UCC” means
the Uniform Commercial Code as enacted in California 

(bb)        “Vendor” means the manufacturer, distributor, or retailer
of the Collateral. 
  

	3.	 Term of Loan and Conditions Precedent: 

(a)        Loan Term. The Loan Term, as to all Collateral designated on
any Loan Schedule, shall include the Supplemental Loan Term commencing on the Advance Date for such Collateral to but excluding the Commencement Date, and shall continue for a Basic Loan Term equal to the initial period ending that number of months
from the Commencement Date as is specified in the applicable Loan Schedule. 

(b)        Procurement, Delivery, and Acceptance. Prior to any
Advance Date, Borrower shall have ordered the personal property that will become Collateral from the Vendor pursuant to one or more Purchase Agreements. Borrower shall be solely responsible for the selection and ordering of the personal property
that will become Collateral. Borrower may instruct or direct Lender, as its agent, to pay Vendor for the personal property that will become Collateral on Borrower’s behalf or, Borrower upon proof or evidence of purchase, may request
reimbursement by Lender for the personal property that will become Collateral previously purchased by Borrower. 

(c)        Obligation to Pay for Personal Property that Will Become
Collateral. Lender may advance such amounts up to $4,600,000 (the “Loan Line”), to purchase any Collateral once all conditions precedent set forth below have been satisfied and subject to the terms and conditions of this Loan
Agreement: (i) with respect to each Advance, Lender and Borrower shall have entered into mutually acceptable loan documentation, including this Loan Agreement, the Loan Schedule; and other ancillary documents and instruments required by Lender,
including sufficiently detailed invoices from the Vendor identifying the personal property that will become Collateral and Collateral Cost (which shall be Appendix A to the Loan Schedule), corporate resolutions and incumbency certificates from
Borrower (substantially in the form of Exhibit C hereto), or other documents evidencing the Borrower’s authority to execute and deliver the Loan, evidence of insurance and “Accord” certificate (pursuant to Insurance
Verification substantially in the form of Exhibit D hereto), appropriate waivers from all potential Collateral lien-holders, including any holders of

 
prior liens on the Collateral, landlord and co-location realities who control access to the Collateral (substantially in the form of Exhibits G, H or I hereto, as applicable), and UCC-1
Financing Statements; (ii) Borrower shall have requested an Advance on personal property that will become Collateral to be placed under a Loan by executing an Request for Advance; (iii) Borrower shall have full legal right, title, and
interest in and to the personal property that will become Collateral, free and clear all liens, claims, and encumbrances, whatsoever; except Lender’s Lien; (iv) all representations and warranties made under each Loan shall be true and
correct, and there shall not exist an Event of Default or any condition, event, or act which with notice or lapse of time would become an Event of Default which has not been remedied or waived, and Borrower shall have fully performed all terms and
conditions required of Borrower under the Loan; (v) there has not been any material adverse change in Borrower’s financial condition or business operations since the date of Lender’s Proposal Letter, (vi) the Collateral Cost
funded under any Loan Schedule shall be not less than $100,000; (vii) Lender shall have approved the financing of the proposed Collateral in Lender’s sole discretion; (viii) no more than 30% of the Collateral Cost under any Loan
Schedule (on a cumulative basis) shall constitute Soft Collateral; and (ix) the funding period for Advances shall not extend beyond June 30, 2011 and shall he subject to Lender’s mandatory 90-day credit review process wherein the line
of credit is reviewed for extension at Lender’s sole discretion and subject to other terms and conditions as Lender may require. 
  

	4.	 Loan Payment, Taxes and Late Payments: 

(a)        Loan Payment. A Daily Loan Payment shall be due during the
Supplemental Loan Term on all Advances made by Lender as requested pursuant to any Request for Advance and shall accrue from the Advance Date with respect to any item of Collateral at the Daily Loan Payment set forth in the applicable Request for
Advance multiplied by the number of days from (and including) the Advance Date to (but not including) the Commencement Date and shall be due and payable on the Commencement Date. The Basic Loan Payment payable hereunder during the Basic Loan Term is
as set forth in the Loan Schedule. Lender and Borrower agree that the Basic Loan Payment described in the Loan Schedule has a corresponding yield relationship to the U.S Treasury obligation and with the closest equivalent maturity as the applicable
Basic Loan Term (“Index Instrument”) as reported in The Wall Street Journal Online on the date of, and quoted in, Lender’s Proposal Letter (or if there is no Proposal Letter, on the date Lender’s investment committee
approves Lender entering into this Loan Agreement or, if applicable, on the date Lender’s investment committee approves any amendment to this Loan Agreement which serves to increase the amount of financing available hereunder), and
consequently, the Basic Loan Payment, Loan Rate Factor, and Balance Due Values Table may be adjusted upward by the Lender on the date of preparation of the Loan Schedule, or alternatively, on the funding date by a Notification of Loan Payment
Adjustment amendment prepared thereafter, to reflect an increase in the reported yield of the Index Instrument over 1.7664%, and downward to provide for a decrease in the yield of the Index Instrument, provided such adjustment shall never be based
on a yield that is less than 1.7664%, and thus reflect such changes in the reported yield of the U.S. Treasury obligation, with the equivalent term of the U.S. Treasury obligation quoted in the Proposal Letter (or the closest term to such original
U.S. Treasury obligation in the event an identical term issue is not reported, and in the event that two or more comparison Treasury obligations are quoted with identical maturities, then with the “Asked” price which is closest to par) in
order to preserve Lender’s anticipated corresponding yield relationship. The Basic Loan Payment shall be fixed as of the date of the Advance and will remain constant through the term of each Loan. Except as may otherwise be provided in any Loan
Schedule, Basic Loan Payment shall begin to accrue on the Commencement Date and shall be due and payable by Borrower on the first day of each period (advance) or the last day (arrears) of each period, as set forth in the applicable Loan Schedule. In
addition to the Basic Loan Payment Borrower shall pay Daily Loan Payment due as indicated in this Loan Agreement, or on any Loan Schedule, or any Rider hereto or thereto. All Loan Payments due by Borrower hereunder is an absolute and unconditional
obligation of 

  

 Page 2 of 8 

 
Borrower which may not be abated or offset for any reason whatsoever as provided in Section 10 hereof. 

(b)        Taxes. In addition to the Loan Payment set forth herein or in
any Loan Schedule, Borrower shall pay and indemnify and hold harmless Lender for an amount equal to all taxes, fees, expenses or charges paid, payable or required to be paid by Borrower, however designated and whenever assessed, which are levied or
based on the Loan Payment, on the Loan, on the Collateral Cost, or on the Collateral or on its purchase, or on its possession, storage, use, lease, operation, control, delivery or value, including as a result of a sale-leaseback or from the Loan
Term expiration, or earlier termination, or from the exercise of any early termination, purchase, or on the Final Payment, or from any conveyance of title to Borrower or Borrower’s designee; including, without limitation, state and local sales,
use, privilege of doing business or excise taxes, taxes based on gross revenue or receipts, any penalties or interest in connection therewith or taxes or amounts in lieu thereof paid or payable in respect of the foregoing, but excluding solely taxes
based on Lender’s net income. Personal property taxes assessed on the Collateral during the term hereof shall be the sole responsibility of and shall be paid on demand by, Borrower. Borrower agrees to file, all required property tax returns and
reports concerning the Collateral with all appropriate governmental agencies, and, within thirty (30) days thereafter to send Lender confirmation of such filing. Borrower shall provide, on an annual basis, a copy of its property tax report
lists to Lender and hereby certifies that all Collateral subject to property tax has been reported to the proper taxing jurisdiction. 

(c)        Late Payments. Interest on any past due Loan Payment and
other payments due and payable shall accrue at the rate of l-1/2% per month from the payment due date, or if such rate shall exceed the maximum rate allowed by law, then at such maximum rate, and shall be payable on demand. Charges for taxes,
penalties and interest shall be promptly paid by Borrower. 
  

	5.	 Installation, Use and Quiet Possession of Collateral: 

(a)        Borrower, shall at all times maintain the Collateral in accordance
with the manufacturer’s specifications and in accordance with prudent industry standards and in accordance with this Loan, specifying maintenance and return conditions for the Collateral. Borrower shall use the Collateral solely for business
purposes, in compliance with the covenants and conditions of all insurance policies required to be maintained by Borrower pursuant to the Loan. Borrower shall, at all times, during the Loan Term assure that the Collateral is maintained in operation
and service in its original intended use. 
 (b)        Any equipment,
supplies spare or replacement parts or other items not specified in the Loan Schedule which are used on or in connection with the Collateral must meet the specifications of the manufacturer and shall be acquired by Borrower at its own expense. The
Borrower shall at all times use the Collateral in compliance with all laws and regulations of all federal, state, local and foreign authorities having jurisdiction thereof. 

(c)        Borrower will at all times keep the Collateral in its sole
possession and control. The Collateral shall not be moved from the location stated in the applicable Loan Schedule without the prior written consent of Lender (said consent not to be unreasonably withheld). 

(d)        After prior written notice to Lender, Borrower may, at its own
expense, make alterations in or add attachments to the Collateral, provided such alterations or attachments do not interfere with the normal and satisfactory operation or maintenance of the Collateral or with Borrower’s ability to obtain and
maintain the maintenance contract required by Section 5(g) hereof. The manufacturer or other organization selected by Borrower to maintain the Collateral (“Maintenance Organization”) may incorporate engineering changes or make
temporary alterations to the Collateral upon request of Borrower. All such alterations and attachments shall be subject to the security interest of Lender, provided that upon an Event of Default, or at the option of Lender, such alterations and
attachments shall be removed by Borrower and the Collateral restored, at Borrower’s expense, to its original condition as of the Acceptance Date

 
thereof, reasonable wear and tear only excepted, and upon the removal and restoration, the alteration and/or attachment which was made by Borrower shall become the property of Borrower free and
clear of the security interest of Lender. 
 (e)        So long as
there shall not exist an Event of Default, or any condition, event, or act which with notice or lapse of time would become an Event of Default, Lender, any party claiming through Lender (except with respect to obligations or claims Borrower is
obligated to perform), or any Assignee shall not interfere with Borrower’s use or possession of the Collateral during the Basic Loan Term. 

(f)        Borrower shall, during the term of this Loan, at its expense, keep
the Collateral in commercially reasonable operating order and condition, reasonable wear and tear excepted, and shall make all necessary adjustments, repairs and replacements, and Borrower shall not use or permit the Collateral to be used in any
manner or for any purpose for which, in the opinion of the manufacturer, the Collateral is not designed or reasonably suitable. Borrower will at all times operate, use, and maintain the Collateral as represented by Borrower in its request for
proposal and/or quotes or as otherwise represented herein or in any other instrument or document prepared by Borrower or its agents. 

(g)        Borrower shall, during the term of this Loan, at its own expense,
maintain each item of Collateral per the manufacturer’s specifications utilizing Borrower’s internal maintenance staff. 

(h)        Upon an Event of Default, at Lender’s demand, pursuant to
Section 9(b)(ii) hereof, Borrower shall, at its expense, deliver the Collateral and all of the service records and all software and software documentation subject thereto to Lender at the location designated by Lender in the same operating
order, repair, condition and appearance as on the Acceptance Date, reasonable wear and tear only excepted, with all engineering and safety changes prescribed by the manufacturer or Borrower’s Maintenance Organization incorporated therein. At
the time of return, the Collateral must be able to perform the function that it was originally intended to perform without additional maintenance. If any computer software requires relicensing when removed from Borrower’s premises, Borrower
shall bear all costs of such relicensing. Borrower shall, prior to such termination, arrange and pay for any repairs and changes as are necessary for the Collateral to satisfy the return condition stated herein and for the manufacturer or
Maintenance Organization to accept the Collateral under contract maintenance at its then standard rates. 
  

	6.	 Borrower Rights and Inspection: 

(a)        The Collateral shall remain personal property regardless of the
manner in which it may be installed or attached. Borrower shall, at Lender’s request, affix to the Collateral, tags, decals or plates furnished by Lender, indicating Lender’s security interest and Borrower shall not permit their removal or
concealment 
 (b)        Borrower shall keep the Collateral free and
clear of all liens and encumbrances except for Lender’s Lien and liens or encumbrances arising through the actions or omissions of Lender which are not otherwise the obligation of Borrower to clear or satisfy hereunder. BORROWER SHALL NOT SELL,
CONVEY, TRANSFER, PART WITH POSSESSION OF, OR ASSIGN OR OTHERWISE ENCUMBER THIS LOAN OR ANY OF ITS RIGHTS HEREUNDER OR SUBLEASE THE COLLATERAL, OR SUFFER A CHANGE IN MAJORITY INTEREST OR CONTROL OF ITS OWNERSHIP IN ANY ONE TRANSACTION OR SERIES OF
RELATED TRANSACTIONS, WITHOUT THE PRIOR WRITTEN CONSENT OF LENDER (SAID CONSENT NOT TO BE UNREASONABLY WITHHELD). EXCEPT AS PERMITTED HEREIN, ANY SUCH PURPORTED TRANSACTION SHALL BE NULL AND VOID AND OF NO FORCE AND EFFECT. BORROWER SHALL NOT BECOME
THE SUBJECT MATTER OF, OR ENTER INTO ANY MERGER OR ACQUISITION TRANSACTION WITH ANY OTHER ENTITY WHICH RESULTS IN SUCH OTHER ENTITY OBTAINING OWNERSHIP OR CONTROL OF OVER FIFTY PERCENT (50%) OF THE EQUITY OF THE BORROWER, WITHOUT THE PRIOR

  

 Page 3 of 8 

 
WRITTEN CONSENT OF LENDER (SAID CONSENT NOT TO BE UNREASONABLY WITHHELD). No permitted assignment or sublease shall relieve Borrower of any of its obligations hereunder. 

Prepayment Requirement. In the event Lender in good faith does not give prior written consent to my event set
forth in this Section 6(b), and such event does not constitute a Permitted Transaction, Borrower shall prepay all Loan Schedules entered into under this Loan Agreement in full by paying to Lender the Prepayment Amount equal to the Balance Due
Value as of the Loan payment date immediately preceding the consummation of any event described in this Section 6(b) plus any other amounts outstanding and owed to Lender under each Loan Schedule. Upon receipt by Lender of all amounts due under
all Loan Schedules, Lender shall, at Borrower’s sole cost and expense, execute such further documents and take such further actions as may be necessary to effect the release of its security interests in the Collateral, including duly executing
and delivering UCC termination statements for filing in any relevant jurisdictions. Nothing in this paragraph is intended to extinguish Lender’s right to indemnifications which by their nature survive the termination of this Loan Agreement or
any Loan Schedule. 
 (c)        Lender or its agents shall have free
access to the Collateral upon twenty-four (24) hours advance notice and any and all records thereto at all reasonable times for the purpose of inspection and for any other purpose contemplated in this Loan, provided, however, no such notice
shall be required if an Event of Default or any condition, event, or act which with notice or lapse of time would become an Event of Default has occurred. Such inspections shall be at Lender’s cost and expense, except that once annually during
the Loan Term, or whenever an Event of Default or any condition, event, or act which with notice or lapse of time would become an Event of Default exists, the inspections shall be at Borrower’s cost and expense. 

(d)        Borrower shall immediately notify Lender of all material details
concerning any damage to, or loss of, the Collateral arising out of any event or occurrence whatsoever, including but not limited to, the alleged or apparent improper manufacture, functioning or operation of the Collateral. 

 

	7.	 Indemnities: 

Borrower will defend, indemnify and hold Lender harmless against any and all suits, judgments, claims, demands and
liabilities of any kind and nature (including without limitation claims relating to environmental discharge, cleanup or compliance, and claims arising out of or in connection with the design, manufacture, possession or operation of the Collateral,
including environmental, product, or strict liability) and all costs and expenses whatsoever to the extent they may be incurred or suffered by Lender or Assignee in connection herewith (including, without limitation, reasonable attorneys’ fees
and expenses), fines, penalties (and other charges of applicable governmental authorities), licensing fees relating to any item of Collateral, damage to or loss or property (including without limitation consequential or special damages to third
parties or damages to Borrower’s property), or bodily injury to or death of any person (including, without limitation, any agent or employee of Borrower). Such indemnities shall continue in full force and effect, notwithstanding the expiration
or termination of this Loan. 
  

	8.	 Risk of Loss on Borrower: 

(a)        Beginning on the Acceptance Date thereof and continuing until the
Loan is terminated and all obligations of Borrower are performed, Borrower relieves Lender of responsibility for all risks of physical damage to or loss or destruction of the Collateral, howsoever caused (including without limitation, accident,
theft, misplacement, condemnation, seizure, forfeiture and abandonment) (“Event of Loss”). During the term of this Loan as to any Loan Schedule, Borrower shall, at its own expense, keep in effect all risk and public liability insurance
policies covering the Collateral designated in each Loan Schedule. The public liability insurance policy shall be in such amount as is reasonably acceptable to Lender. Any increase in the amount of such insurance coverage reasonably requested by
Lender 

 
shall be put into effect on the next succeeding renewal date of such insurance. The all risk insurance policy shall be for an amount not less than the higher of replacement cost of the Collateral
or the Balance Due Value. Lender, its successors and assigns and/or such other party as may be designated by any thereof to Borrower, in writing, shall be named as additional insured and/or loss payees on such policies, which shall be written by an
insurance company of recognized responsibility which is reasonably acceptable to Lender. Evidence of such insurance coverage shall be furnished to Lender no later than the Acceptance Date set forth in the Loan Schedule(s) and, from time to time,
thereafter as Lender may request. Such policies shall provide that no less than thirty (30) days written notice shall be given Lender and any other party named as loss payee prior to cancellation of such policies for any reason. If the Borrower
fails to provide evidence of such insurance or to deliver evidence of renewal of each such policy then Borrower agrees to pay Lender a non-compliance fee equal to 1% of the Collateral Cost for all Collateral covered under this Loan each month until
such evidence is provided to Lender. Borrower hereby irrevocably appoints Leader or any other party named as loss payee as Borrower’s attorney-in-fact coupled with an interest, so long as a default or Event of Default hereunder exists and is
continuing to negotiate and make claim for, receive payment of, and execute any and all documents that may be required to be provided to the insurance carrier in substantiation of any such claim for loss or damage under said insurance policies, and
to endorse Borrower’s name to any and all drafts or checks in payment of the loss proceeds. 

(b)        If any item of Collateral is damaged or suffers an Event of Loss,
Borrower shall give to Lender immediate notice thereof and this Loan shall continue in full force and effect without any abatement of Loan Payment. Lender shall determine, within twenty (20) days after the date of occurrence of such damage or
Event of Loss, whether such item of Collateral can be repaired. In the event Lender determines that such item of Collateral can be repaired, Borrower shall cause such item of Collateral to be promptly repaired. In the event Lender determines that
the item of Collateral cannot be repaired, Borrower shall at Lender’s election, either: (i) promptly replace such item of Collateral with equipment of like or better kind, make and model, utility and value free and clear of all liens and
encumbrances except for Lender’s Lien, and this Loan shall continue in full force and effect as though such damage or destruction had not occurred; or (ii) pay to Lender an amount equal to the Balance Due Value for the item of Collateral
for the Loan Payment due date immediately preceding the Event of Loss and this Loan will terminate as to the item of Collateral suffering the Event of Loss and the Loan Payment under the applicable Loan Schedule shall be reduced thereafter pro rata
by the reduction of the original Collateral Cost of the item of Collateral suffering the Event of Loss. All proceeds of insurance received by Lender, the designated loss payee, or Borrower under the policy referred to in the preceding paragraph of
this Section shall be applied toward the cost of any such repair or replacement so long as Borrower shall not be in default of its obligations hereunder. 
  

	9.	 Events of Default and Remedies: 

(a)        Events of Default. The occurrence of any one of the following
shall constitute an Event of Default hereunder: 
 (i)        Borrower
fails to pay an installment of Loan Payment or other payment within five (5) days after the date when the same becomes due and payable. 

(ii)        Borrower attempts to remove, sell, transfer, encumber, sublet or
part with possession of the Collateral or any items thereof, except as expressly permitted herein. 

(iii)        Borrower breaches or shall have breached any material
representation or warranty made or given by Borrower in this Loan or in any other document furnished to Lender in connection herewith (provided that any breach of a representation or warranty that has a bearing on the Lender’s credit,
economics, or collateral security considerations under this Loan shall be deemed to be material), or any such representation or warranty shall be untrue or, by reason of failure to state a material fact or otherwise, shall be misleading or any of
the statements or other documents 

  

 Page 4 of 8 

 
or information submitted at any time heretofore or hereafter by Borrower to Lender shall be untrue or, by reason of failure to state a material fact or otherwise, shall be misleading to the
extent individually or in the aggregate could reasonably be expected to result in a material adverse effect on Borrower’s business. 

(iv)        Borrower shall fail to observe or perform any of the other
obligations required to be observed or performed by Borrower hereunder and such failure shall combine uncured for thirty (30) days after written notice thereof to Borrower by Lender or the then Assignee hereof. 

(v)        Borrower shall be in material breach of or in default under any
lease, loan, or other agreement or obligation at any time executed (i) with Lender in any amount, or (ii) with any other lessor, lender, or other creditor in the amount of $100,000 or more, which results in actual acceleration of
indebtedness. 
 (vi)        Borrower ceases doing business as a going
concern, makes an assignment for the benefit of creditors, admits in writing its inability to pay its debts as they become due, files a voluntary petition in bankruptcy, is adjudicated a bankrupt or an insolvent, files a petition seeking for itself
any reorganization, arrangement, composition, readjustment, liquidation, dissolution or similar arrangement under any present or future statute, law or regulation or files an answer admitting the material allegations of the petition filed against it
in any such proceeding, consents to or acquiesces in the appointment of a trustee, receiver, or liquidator of it or of all or any substantial part of its assets or properties, or if it or its shareholders shall take any action looking to its
dissolution or liquidation. 
 (vii)        Within thirty
(30) days after commencement of any proceedings against Borrower seeking reorganization, arrangement, readjustment, liquidation, dissolution or similar relief under any present or future statute, law or regulation, such proceedings shall not
have been dismissed, or if within thirty (30) days after the appointment without Borrower’s consent or acquiescence of any trustee, receiver or liquidator of it or of all or any substantial part of its assets and properties, such
appointment shall not be vacated. 
 (viii)        Borrower becomes
the subject matter of, or enters into any Change in Control without the prior written consent of Lender. 

(ix)        Borrower fails to comply with its insurance obligations under
Section 8 (a). 
 Any Event of Default shall be deemed material and a substantial impairment of
Lender’s interests for the purpose of this Loan, the UCC, and any other applicable law. 

(b)        Remedies. Upon the occurrence of an Event of Default, Lender
may at its option do any of the following: (i) by notice to Borrower terminate this Loan as to any or all Loan Schedules; (ii) whether or not this Loan is terminated as to any or all Loan Schedules, take possession of any or all of the
Collateral listed on any or all Loan Schedules, wherever situated, and for such purpose, enter upon any premises without liability for so doing or Lender may cause Borrower and Borrower hereby agrees, to return said Collateral to Lender as provided
in this Loan; (iii) recover from Borrower any and all past due payments, and, as liquidated damages for loss of a bargain and not as a penalty, an amount equal to the Balance Due Value of all Collateral calculated as of the Loan Payment date
preceding the date that the event which resulted in the Event of Default occurred, which payment shall become immediately due and payable; and (iv) sell, dispose of, hold, use or lease any Collateral as Lender in its sole discretion may
determine. Lender reserves the right, in its sole and absolute discretion, to control the timing and negotiate the terms of any re-leasing or re-sale of any or all of the Collateral at a public auction or in a private sale, at such time, on such
terms and with such notice as Lender shall in its sole and absolute discretion deem commercially reasonable. 

(c) Mitigation. In the event that Borrower shall have paid to Lender or its Assignee, (as hereinafter defined),
the liquidated damages

 
referred to in Section 9(b)(iii) above, and Borrower shall have previously returned the Collateral to Lender in accordance with Section 9(b)(ii) above, then Lender or its Assignee shall
pay to Borrower, promptly after receipt thereof, all sale or rental proceeds received from any sale or re-letting of the Collateral during the balance of the Basic Loan Term (after deduction of all unreimbursed damages, costs and expenses incurred
by Lender as a result of the Event of Default; or other sums due Lender by Borrower under the Loan) said amount never to exceed the amount of the liquidated damages paid by Borrower. Lender shall use commercially reasonable efforts to sell, re-lease
or otherwise use or dispose of the Collateral in mitigation of damages to the extent required by law (however, Lender shall not be obligated to give preference to the sale, lease or other disposition of the Collateral over the sale, lease or other
disposition of similar collateral owned or leased by Lender). 

(d)        Other Damages. Notwithstanding the exercise by Lender or its
Assignee of any of the remedies found in Section 9(b) above, Borrower shall, in any event remain fully liable for reasonable damages as provided by law and for all reasonable costs of collection and reasonable expenses incurred by Lender or its
Assignee on account of such Event of Default including but not limited to all expenses of selling or leasing the Collateral (including broker’s and sales representative’s fees and commissions), cleaning and repainting, storage costs,
repossession costs, court costs and reasonable attorney’s fees. Borrower hereby agrees that, in any event, it will be liable for any deficiency after any lease or other disposition of the Collateral. The rights afforded Lender hereunder shall
not be deemed to be exclusive, but may be exercised concurrently and shall be in addition to any other rights or remedies provided to creditors or lenders under the UCC or otherwise by law or equity. 

 

	10.	 Borrower’s Loan Obligations: 

It is understood and agreed as between Lender and Borrower, Borrower shall be responsible for all costs and expenses of
every nature whatsoever arising out of or in connection with or related to this Loan or the Collateral, or its possession, ownership, or use (including, but not limited to, taxes, insurance, maintenance, transportation in and out, rigging, drayage,
packing, installation and disconnect charges). Borrower’s obligations hereunder (including its obligation to pay Loan Payment when and as due without notice or demand, or any other sum due hereunder upon demand) are absolute and unconditional,
and (i) may not be terminated, rescinded or revoked for any reason whatsoever, except pursuant to the express provisions hereof, and (ii) shall not be subject to any abatement, reduction, recoupment, defense, offset or counterclaim
available to Borrower for any reason whatsoever including operation of law, defect in the Collateral, failure of Lender or any Assignee to perform any of its obligations hereunder or for any other cause or reason whatsoever, whether similar or
dissimilar to the foregoing. Borrower hereby waives any and all defenses or claims Borrower may assert against Lender or any Assignee, whether now or in the future, and which would prevent Borrower from performing its obligations hereunder,
including, without limitation, defect in the Collateral, interference with the Borrower’s use, operation or possession of the Collateral, failure of the Lender or of any Assignee to perform my of its obligations hereunder, the liability or
indebtedness of Lender or any Assignee to Borrower or any other person, or the bankruptcy, insolvency or default of the Lender or any Assignee. In the event this Loan is terminated prior to its expiration by agreement or otherwise between Lender or
Borrower or for any other reason whatsoever, including, without limitation, early termination, casualty loss, or default, then Borrower shall be responsible and agrees to pay any and all costs and expenses and/or liabilities of Lender as a result
thereof, including taxes and any pre-payment penalties, fees or charges assessed by any Assignee against Lender or Borrower. Borrower hereby agrees that in the event that Borrower fails to pay or perform any obligation under this Loan, Lender may,
at its option, pay or perform said obligation and any payment made or expense incurred by Lender in connection therewith shall become additional Loan Payment which shall be due and payable by Borrower upon demand.

  

 Page 5 of 8 

 11.    Assignment: 

(a)        Borrower agrees that Lender may transfer or assign all or any part
of Lender’s right, title and interest in, under or to the Collateral and this Loan and any or all sums due or to become due pursuant to any of the above, to any affiliate of Lender (the “Assignee”) for any reason and the Assignee may
so reassign and transfer to another affiliate of Lender. Borrower agrees that upon receipt of written notice from Lender or Assignee of such assignment, Borrower shall perform all of its obligations hereunder for the benefit of Assignee and any
successor assignee and, if so directed, shall pay all sums due or to become due hereunder directly to the Assignee or to any other party designated by the Assignee. Borrower hereby covenants, represents and warrants as follows, and agrees that the
Assignee and any successor assignee shall be entitled to rely on and shall be considered a third party beneficiary of the following covenants, representations and warranties: (i) Borrower’s obligations hereunder are absolute and
unconditional; (ii) may not be terminated, rescinded or revoked for any reason whatsoever, except pursuant to the express provisions hereof, (iii) shall not be subject to any abatement, reduction, recoupment, defense, offset or
counterclaim available to Borrower for any reason whatsoever including operation of law, defect in the Collateral, failure of Lender or Assignee to perform any of its obligations hereunder or for any other cause or reason whatsoever, whether similar
or dissimilar to the foregoing; (iv) unless otherwise provided in the Notice and Acknowledgment of Assignment, Borrower shall not look to Assignee or any successor assignee to perform any of Lender’s obligations hereunder;
(v) Borrower will not amend or modify the Loan without the prior written consent of the Assignee; and (vi) Borrower will send a copy to Assignee and any successor assignee of each notice which Borrower sends to Lender. 

(b)        Upon receipt of notice of any such assignment, Borrower agrees to
execute and deliver to Lender such documentation as Assignee or any successor assignee may reasonably require, including but not limited to a Notice and Acknowledgment of Assignment in the form of Exhibit E hereto which requires Borrower to
make certain representations or reaffirmations as to some of the basic terms and covenants contained in this Loan, and (ii) an opinion of counsel for the Borrower. Unless otherwise indicated in the Notice and Acknowledgment of Assignment,
Lender shall not be relieved of any of its obligations hereunder, and the rights of Borrower hereunder shall not be impaired. 

12.    Ownership and Tax Treatment: 

Borrower shall be deemed the owner of the Collateral for all purposes, including Federal and State income taxes, and
all applicable sales, use, and property taxes, and for FASB accounting purposes. 
 13.    Representations and Warranties
of Borrower: 
 The Borrower represents and warrants to the Lender that the following are true and correct
on the date the Borrower executes any Loan: 
 (i)        The Borrower
is duly formed and validly existing under the laws of the State of its organization, and has the full power and authority and legal right to carry on its business as is now conducted, and is duly qualified to do business in the jurisdictions where
the Collateral is or will be operated. 
 (ii)        The Loan has
been duly authorized, executed and delivered by the Borrower, and, constitutes the valid, legal and binding agreement of the Borrower, enforceable against the Borrower in accordance with its terms. 

(iii)        The execution and delivery by the Borrower of the Loan and the
Borrower’s compliance with all of the provisions of the Loan are within the powers of the Borrower, and will not, to the best of Borrower’s knowledge, conflict with or result in a breach of any presently existing law or governmental rule,
regulation order, writ, injunction or decree. 

 

 (iv)        No authorization or
approval from, consent of, or filing, registration or qualification with, any state, federal or local governmental or public body or authority, except as has been obtained or made, is necessary for the execution or delivery by the Borrower of the
Loan, or the validity of the Loan or the operation and leasing of the Collateral by the Borrower. 

(v)        The Borrower, has not directly or indirectly offered, sold,
encumbered or transferred any interest in the Collateral or solicited offers to buy, encumber or transfer any such interest from, anyone other than the lender. The Vendor of the Collateral is not affiliated with the Borrower and, to the best of
Borrower’s knowledge, Lender has received the benefit of any and all discounts or rebates thereto, and Borrower has not received directly any such rebates, discounts, kickbacks or reimbursements. 

(vi)        Lender’s interest in each item of Collateral will be free of
all claims, liens and encumbrances arising by, through or under the Borrower other than pursuant to the terms of this Loan. 

(vii)        The Borrower is not in violation of any order of any court,
arbitrator or governmental body material laws, ordinances or governmental rules or regulations (domestic or foreign) to which it is subject, or with respect to any material loan agreement, debt instrument or contract with a supplier or customer of
Borrower and has not failed to obtain or apply for any licenses, permits, franchises or other governmental authorizations necessary to the ownership of its property (including the Collateral) or to the conduct of its business. 

(viii)        There are no suits or proceedings pending or, to the knowledge of
the Borrower, threatened in any court or before any regulatory commission, board or other governmental administrative agency against or affecting the Borrower which if determined adversely to Borrower would materially adversely affect
Borrower’s business as presently conducted or its ability to perform its obligations hereunder. 

(ix)        Neither the Loan, nor any written statement furnished to the Lender
by the Borrower hereby, contains any untrue statement of a material fact or omits a material fact necessary to make the statements contained therein not misleading. 

(x)        All applications, financial statements and Borrower Reports, and all
information hereafter furnished by Borrower and Guarantor to Lender will be, true and correct in all material respects as of the date submitted; 

(xi)        As of the date hereof, the date of any Loan Schedule and of any
Acceptance Date, there has been no material adverse change in any matter stated in such Borrower Reports which have been submitted, by Borrower and/or any Guarantor to Lender. 

(xii)        Neither Borrower nor any Guarantor has omitted to state any
material fact which would make any of the foregoing false or misleading in light of the circumstances under which made. 

(xiii)        The Borrower’s principal place of business, chief executive
office, and state of incorporation (as such terms are used in the UCC) are indicated in the heading hereof. 

(xiv)        Since the date of the Proposal Letter issued by Lender in
connection with this transaction, and as of the date of Borrower’s latest Borrower Reports, which have been previously submitted by Borrowed to Lender, there has not been any material adverse change in the contemplated business, operations,
properties or financial condition of the Borrower. 

(xv)        The Borrower will use the Collateral in accordance with its
original request for quote or proposal, or any other written or oral representations made concerning the usage of the Collateral. The Collateral will be used “predominately” in the United States as such term is used in the Internal Revenue
Code. 

  

 Page 6 of 8 

 (xvi)        The Collateral shall
at all times remain the property of Borrower. Borrower will at all times protect and defend at its own cost and expense, the security interest of Lender against all claims, liens and legal processes of creditors of Borrower and other persons
claiming by, through or under Borrower, and keep the Collateral free and clear from all such claims, liens and processes. The Collateral is and shall remain personal property, and not part of any real estate, with the exception of lease hold
improvements, or Borrower shall have obtained from all applicable real property interest holders appropriate consents, waivers, and releases as reasonably requested by Lender. 

14.    End-of-Loan Position: 

Borrower’s End-of-Loan position with respect to my Loan is as set forth on the applicable Loan Schedule,

 15.    Miscellaneous: 

(a)        Choice of Law. No consent or approval provided for herein
shall be binding upon Lender unless signed on its behalf by an officer of Lender. This Loan Agreement and each Loan shall be deemed to have been made in the State of California and shall be governed in all respects by the laws of such State. Lender
and Borrower hereby submit themselves to the jurisdiction of the State and Federal courts in San Francisco, California for any matter or controversy arising from any Loan. In the event any provision of this Loan is enforced in a court of law, or any
other judicial or administrative setting, then the party succeeding in such matter or controversy shall also be awarded all of its attorney’s fees and court costs and other expenses incurred in the pursuit or defense of such matter or
controversy (including, without limitation, the defense of any counter-claims forwarded by the losing party). 

(b)        Entire Agreement. This Loan constitutes the entire agreement
between Borrower and Lender with respect to the Collateral, supersedes all prior oral or written agreements and understandings, and no covenant, condition or other term or provision hereof may be waived or modified orally. 

(c)        Notices. All notices hereunder shall be in writing, and any
such notice shall become effective (i) the following day upon delivery thereof to an overnight mail or courier service, (ii) in the case of notice by first class United States mail, three days after being so deposited in the United States
mail, or (iii) in the case of notice by facsimile transmission, immediately upon transmission, in each case addressed to the appropriate party at its respective address set forth above in the caption heading of this Loan, or at such other
address as such party may from time to time designate by written notice to the other party to the address indicated in the heading of this Loan Agreement. 

(d)        Successors and Assigns. This Loan shall be binding upon and
inure to the benefit of Lender and Borrower and their respective successors and assigns (including any subsequent assignee of Assignee). 

(e)        Unenforceability. If any term or provision of this Loan or
the application thereof to any person is, to any extent, invalid or unenforceable, the remainder of this Loan, or the application of such provision to the person other than those to which it is invalid or unenforceable, shall not be affected
thereby, and each provision of this Loan shall be valid and be enforced to the fullest extent permitted by law, provided however, that to the extent that the provisions of any such applicable law can be waived, they are hereby waived by the
Borrower. 
 (f)        Waivers and Consents. No waiver,
approval, or consent of any of the terms and conditions hereof shall be effective unless in writing and signed by the party against whom such waiver, approval, or consent is sought to be enforced. Any waiver, approval or consent granted by the
Lender are only effective if signed by an authorized officer of the Lender. Any waiver of the terms hereof shall be effective only in the specific instance and for the specific purpose given. 

 

 (g)        Further Assurances,
Financing Statements, Fees and Costs. Borrower agrees to execute any and all other documents, instruments and agreements, reasonably requested by the Lender in furtherance of the intent of the parties herein. Lender is hereby authorized by
Borrower to cause this Loan or other installments, including Uniform Commercial Code Financing Statements, to be filed or recorded for the purpose of showing Lender’s interest in the Collateral and Borrower agrees that Lender may execute such
instruments for and on behalf of Borrower. Borrower shall pay Lender a transaction fee of $10,000 and for any costs or fees relating to any filings hereunder and other transactional costs including, but not limited to, actual out of pocket costs,
fees, searches, documentation preparation, documentary stamps, privilege taxes and reasonable attorneys’ fees, Borrower agrees that it shall pay, in addition to the amounts referred to above, any additional reasonable fees for outside legal
counsel retained by Lender to prepare Loan or Warrant documentation. In addition a .5% facility fee based on the availability of each of Tranche 1 and Tranche 2 shall be due on or prior to the Advance Date of the first Loan Schedule funded under
each such Tranche. 
 (h)        Conflict. In the event of
any conflict between the terms and conditions of this Loan Agreement and the terms and conditions of any Loan Schedule or Rider thereto, the terms and conditions of such Loan Schedule or Rider shall prevail. 

(i)        Financial Statements. During the term of this Loan for any
period of time in which Borrower is not filing its financial statements with the Securities and Exchange Commission, Borrower hereby agrees to deliver to Lender or Assignee and any successor assignee a copy of Borrower’s and Guarantor’s
(i) annual audited financial statements including cash flow statement within one-hundred and twenty (120) days after the end of its fiscal year; (ii) quarterly unaudited financial statement including cash flow statement within sixty
(60) days after the end of its fiscal quarter; and (iii) at the request of Lender, for each month, monthly unaudited financial statement, plus, for each month that is at the end of a Borrower’s fiscal quarter, a cash flow statement,
all within thirty (30) days after the end of each month or at such other times as Lender may reasonably request. Financial statements available on the public domain will be considered delivered as satisfaction of this reporting requirement. So
long as there are amounts due Lender under this Loan, Borrower shall supply Lender with such other financial and operating performance data as is provided to its outside investors or commercial lenders and, if applicable, required to be provided to
shareholders by the Security and Exchange Commission, and Borrower shall immediately notify Lender of any material adverse change in its (mender condition or business prospects. 

(j)        Survival. Any obligation required to be performed by Borrower
under this Loan, which by their nature, or expressly survive the termination of this Loan (including, without limitation, the obligations identified in Sections 4, 5, 6, 7, 8, 9, 10 and 15(a)), shall survive the expiration or other termination of
this Loan for the period prescribed by applicable law. 

(k)        Use of Information. Borrower shall permit Lender to list
Borrower’s name and logo and to describe the transaction contemplated herein in Lender’s marketing materials and to post such information on Lender’s website. Borrower agrees to list Lender as an investor on Borrower’s website
and to enter into a mutually agreeable press release announcing the financing contemplated by this Loan Agreement 

(l)        Advances are Discretionary. Notwithstanding anything to the
contrary, all Advances to be made by Lender hereunder are discretionary and not mandatory and Lender shall have no obligation to pay a Vendor for the Collateral on Borrower’s behalf; or reimburse Borrower for Collateral previously purchased
unless all conditions precedent set forth in Section 3(c) have been satisfied, and otherwise Lender, in its sole and absolute discretion, elects to do so. 

(m)        Payments. Borrower authorizes Lender to debit the Loan
Payments by electronic credit (e.g., automated clearinghouse payment) (the “ACH Payments”) from Borrower’s deposit account and Borrower shall

  

 Page 7 of 8 

 
provide Lender with the ACH Payment information and instructions prior to funding of an Advance hereunder. 

16.    Loan Status; California Finance Lenders Law; Security Interest: 

Lender and Borrower agree that Article 9 of the UCC governs the terms of this Loan. This Loan is made pursuant to the
California Finance Lenders Law, Division 9 (commencing with Section 22000 of the California Financial Code). Lender is a California Finance Lender with California Finance Lender’s License No. 605-2302. FOR INFORMATION, CONTACT
THE DEPARTMENT OF CORPORATIONS, STATE OF CALIFORNIA. Borrower hereby grants to Lender a security interest pursuant to Article 9 of the UCC as follows (the “Lender’s Lien”): 

BORROWER HEREBY GRANTS TO LENDER A SECURITY INTEREST IN THE COLLATERAL WHETHER NOW OWNED BY BORROWER OR HEREAFTER
ACQUIRED, WHICH IS DESCRIBED ON ANY LOAN SCHEDULE ENTERED INTO BY LENDER AND BORROWER AND WHICH INCORPORATES THIS LOAN AGREEMENT BY REFERENCE, AND ANY ATTACHMENTS, ADDITIONS, ACCESSIONS, SUBSTITUTIONS AND REPLACEMENTS THERETO, AND ANY PROCEEDS
THEREOF (INCLUDING WITHOUT LIMITATION, INSURANCE PROCEEDS) AND BORROWER HEREBY AGREES TO PERMIT LENDER TO FILE ANY AND ALL UCC FINANCING STATEMENTS REQUIRED IN ACCORDANCE WITH SECTION 15(h)

 
HEREOF. LENDER SHALL RETAIN LENDER’S LIEN ON ALL LOAN SCHEDULES UNTIL BORROWER HAS PERFORMED ALL OBLIGATIONS AND PAID IN FULL ALL AMOUNTS DUE UNDER ALL LOAN SCHEDULES. 

17.    Termination of Agreement and Security Interests: 

This Agreement shall continue in full force and effect until all of the Advances have been paid in full to Lender or
its assignee at which time this Agreement and all security interests granted hereby shall terminate, provided, that Debtor’s indemnity obligations set forth in Section 7 shall survive until all applicable statutes of
limitations periods with respect to actions that may be brought against Borrower have run. 
 18.    Prepayment: 

 Borrower shall have the right to prepay any Advance made pursuant to this Agreement by paying to Lender the
Balance Due Value with respect thereto as of the Loan Payment date immediately preceding the date of prepayment, plus any outstanding fees, taxes, costs or other reimbursements (including any indemnities) owing to Lender (in the aggregate, the
“Prepayment Amount”). 
 (Remainder of page intentionally left blank)

  
 NO INTEREST IN THE
LOAN PAYMENT DUE OR THE RIGHTS OF THE LENDER UNDER ANY LOAN OF COLLATERAL CAN BE TRANSFERRED BY THE DELIVERY OF POSSESSION OF ANY COUNTERPART OF THIS LOAN AGREEMENT. SUCH AN INTEREST CAN BE TRANSFERRED ONLY BY DELIVERY OF POSSESSION OF THE
ORIGINAL SIGNED COUNTERPART NO. 1 OF A LOAN SCHEDULE EXECUTED PURSUANT HERETO. 
  

									
	LENDER:	    	BORROWER:	  	
	ATEL VENTURES, INC.	    	AMYRIS BIOTECHNOLOGIES, INC.	  	
					
	 By:
	 	 /s/ Paritosh K. Choksi
	    	 By:
	 	 /s/ Tamara Tompkins
	  	
					
	 Title:
	 	 Executive Vice President
	    	 Title:
	 	 General Counsel
	  	

 Attachments: 

Exhibit A-Form of Loan Schedule 

Exhibit B-Form of Request for Advance 

Exhibit C-Form of Corporate Resolution and Incumbency Certificate 

Exhibit D-Form of Request for Evidence of Insurance 

Exhibit E-Form of Notice and Acknowledgment of Assignment 

Exhibit F-Consent to Removal of Personal Property 

Exhibit G-Waiver Agreement 

Exhibit H-Bailee Waiver and Agreement 

 

 Page 8 of 8 

 [EXHIBIT A] 

COUNTERPART NO. OF MANUALLY EXECUTED COUNTERPARTS. ONLY THE MANUALLY EXECUTED COUNTERPART NUMBERED “1” SHALL BE DEEMED
“CHATTEL PAPER” AS SUCH TERM IS DEFINED IN THE UNIFORM COMMERCIAL CODE AND IS SUFFICIENT TO TRANSFER LENDER’S INTEREST, OR TO GRANT A SECURITY INTEREST HEREIN. 

LOAN SCHEDULE NO.      to 

MASTER LOAN AND SECURITY AGREEMENT NO. AMYRX (the “Loan”) 

dated as of JUNE 1, 2010, by and between 

ATEL VENTURES, INC. (“Lender”) and AMYRIS BIOTECHNOLOGIES, INC. (“Borrower”) 

 

	1.	 Collateral Description:             [See Appendix A hereto]

	[QTY	 MODEL/FEATURE/DESCRIPTION VENDOR/MANUFACTURER SERIAL NO.] 

Collateral previously purchased shall be allowed to be financed. The advancement rate will be at Invoice cost for
Collateral 90 days old or newer. Collateral older than 90 days but not older than an invoice date of April 1, 2009, shall be advanced at net book value based on three year straight line depredation. Depreciation can be financed as Soft
Collateral as long as the amounts advanced do not exceed 30% of the outstanding balance of the facility, subject to Section 3(c) of the Loan Agreement. The soft cost allocation can be used for sales tax, freight, installation costs, training,
depreciation and assets of specific `nature with undeterminable resale value. 
  

	2.	 Collateral Cost:       [See Appendix A hereto] 

 

	3.	 Collateral Location: 

  

	4.	 Acceptance Date:      the date indicated on the Request for Advance executed pursuant hereto as the Acceptance Date.

  

	5.	 Commencement Date:  The Commencement Date shall be the first day of the calendar month following the Advance Date of the Collateral, or
if the Advance Date is the first day of the calendar month, on such day,
[                             , 20    ].

  

	6.	 Advance Date: the date indicated on the Request for Advance as the Advance Date,
[                             , 20    ]

  

	7.	 Basic Loan Term:      42 months 

 

	8.	 Basic Loan Payment:               In Advance,
$                     per month. The first and last Basic Loan Payments shall be due on the Commencement Date, and at Lender’s option,
may be deducted from the Collateral Cost funded on the Advance Date. 

  

	9.	 Loan Rate Factor:  The Basic Loan Payment is conditional upon Lender acquiring the Collateral at the Collateral Cost indicated above.
Lender and Borrower agree that the Basic Loan Payment described herein is based on a Loan Rate Factor of 2.944% which equates to $29.44 for each full $1,000 of Collateral Cost and that the Basic Loan Payment shall be adjusted upwards or downwards by
such Loan Rate Factor to the extent by which the actual purchase price paid by Lender for the Collateral (“Actual Cost”) is greater or lesser than the Collateral Cost indicated above, and thereafter, the Actual Cost shall be the Collateral
Cost. Lender and Borrower further agree that the Basic Loan Payment and Loan Rate Factor described herein may be adjusted in accordance with the provisions of Section 4(a) of the Loan Agreement 

 

	10.	 Riders:      Rider No. 1 to the Loan Schedule — Balance Due Values is incorporated herein by reference.

  

	11.	 Loan Agreement:  All of the terms, covenants and conditions set forth in the Loan are incorporated herein by reference as if the same
had been set forth herein in full. 

 12.
          End-of—Loan Requirement:  At the expiration of the Basic Loan Term of this Loan, Borrower shall make a Final Payment equal to seven and one-half percent (7.5%) of the
original Collateral Cost for all and not less than all the Collateral set forth on this Loan Schedule. 
 Lender shall provide a
Notification of Schedule Adjustment to Borrower should the Commencement Date or the Basic Loan Payment be adjusted as provided for in Paragraph9 above. 
  

											
	 ATEL VENTURES, INC.
	 		 	 AMYRIS BIOTECHNOLOGIES, INC.
	 	
						
	 By:
	 	  
	 		 	 By:
	 	  
	 	
						
	 Title:
	 	  
	 		 	 Title:
	 	  
	 	
						
	 Date:
	 	  
	 		 	 Date:
	 	  
	 	

  

 Exhibit A - Page 1 

 RIDER NO. 1 

TO LOAN SCHEDULE NO. 1 

TO MASTER LOAN AND SECURITY AGREEMENT NO. AMYRX 

dated as of JUNE 1, 2010 (the “Loan”) between 

ATEL VENTURES, INC. as Lender and AMYR1S BIOTECHNOLOGIES, INC., as Borrower 

Balance Due Value:  means the product of the corresponding percentage indicated below, for the Loan Payment date immediately
preceding the date that the event which caused an Event of Loss occurred, an Event of Default occurred, or a Prepayment occurred times the Collateral Cost of the item of Collateral suffering the Event of Loss or of all Collateral in the event of an
Event of Default or Prepayment. 
  

			
	        Period	    	Balance Due Value
(% of Collateral Cost)
	 1
	    	104.11%    
	2	    	102.24%    
	3	    	100.35%    
	4	    	98.43%    
	5	    	96.49%    
	6	    	94.53%    
	7	    	92.54%    
	8	    	90.53%    
	9	    	88.49%    
	10	    	86.43%    
	11	    	84.34%    
	12	    	82.23%    
	13	    	80.09%    
	14	    	77.93%    
	15	    	75.73%    
	16	    	73.51%    
	17	    	71.27%    
	18	    	68.99%    
	19	    	66.69%    
	20	    	64.36%    
	21	    	62.00%    
	22	    	59.61%    
	23	    	57.19%    
	24	    	54.73%    
	25	    	52.25%    
	26	    	49.74%    
	27	    	47.20%    
	28	    	44.62%    
	29	    	42.01%    
	30	    	39.37%    
	31	    	36.69%    
	32	    	33.98%    
	33	    	31.24%    
	34	    	28.46%    
	35	    	25.65%    
	36	    	22.80%    
	37	    	19.91%    
	38	    	16.99%    
	39	    	14.03%    

  

 Exhibit A - Page 2 

			
	 40
	    	                   11.03%    
	 41
	    	7.99%    
	 42
	    	7.86%    
	 43
	    	0.23%    

Balance Due Values are due in addition to any Basic Loan Payment due on the same day. 

                   
                                         
                                         
                                         
           
  

							
	 AMYRIS BIOTECHNOLOGIES, INC.

				
	 By:
	 	  
	 		 	
				
	 Title:
	 	  
	 		 	
				
	 Date:
	 	  
	 		 	

  

 Exhibit A - Page 3 

 APPENDIX A 

TO LOAN SCHEDULE NO. 1 

TO MASTER LOAN AND SECURITY AGREEMENT NO. AMYRX 

dated as of June 1, 2010 (the “Loan”) between 

ATEL VENTURES, INC. as Lender and
                             as Borrower 

[INSERT COLLATERAL DESCRIPTION) 
  

 Exhibit A - Page 4 

 [EXHIBIT B] 

MASTER LOAN AND SECURITY AGREEMENT NO. AMYRX (the “Loan”) 

dated as of JUNE 1, 2010, by and between 

ATEL VENTURES, INC. (the “Lender”) and AMYRIS BIOTECHNOLOGIES, INC. (the “Borrower”) 

REQUEST FOR ADVANCE NO.     -     

WHEREAS, AMYRIS BIOTECHNOLOGIES, INC. (“Borrower”) will execute a Loan Schedule [No. __] to a certain
Master than and Security Agreement dated JUNE 1, 2010, (the Loan Schedule, as it incorporates or will incorporate the term of the Loan Agreement, hereinafter referred to as the “Loan”) between itself and ATEL VENTURES, INC.
(“Lender”), and 
 WHEREAS, said Loan Schedule lists or will list certain Collateral leased
thereunder more fully described on Appendix “A” hereto (“Collateral”); 
 NOW,
THEREFORE, (i) Borrower requests that Lender make an Advance [to Borrower] [to the Vendor of the Collateral] pursuant to the terms and in the amounts indicated on the attached invoice(s) totaling
$             (“Collateral Cost”, please see attached Appendix “A”). (The date of any such payment shall be set forth below and known as the “Advance
Date”); and (ii) Borrower acknowledges (where applicable) delivery, receipt and installation of all Collateral listed on said Collateral Appendix A at the location indicated on the attached Appendix A, which Collateral, delivery, and
installation has been inspected and found satisfactory. On the Advance Date indicated below, Borrower affirms that the Collateral has been “placed in service” as such icon is used in the Internal Revenue Code and is acceptable to Borrower
for loan hereunder and hereby requests that Lender make an Advance with respect thereto. Borrower agrees that Lender may fill in the Advance Date below on the date the Collateral Cost is advanced. 

Borrower agrees that pursuant to the terms of the Loan, the Daily Loan Payment is
$                 in total which equals $                 multiplied by the
number of days from (and including) the Advance Date to but not including) the Commencement Date of the Loan Schedule and shall be due and payable on the Advance Date and such Daily Loan Payment is due without right of deduction, offset, abatement
defense, counterclaim or demand whatsoever. The Basic Loan Payment for the Collateral accepted hereunder is $                 per month, and is due monthly in
advance without right of deduction, offset, abatement, defense, counterclaim or demand whatsoever on the Commencement Date and on the first thy of each month thereafter for          months. If for any
reason the Borrower and the Lender fail to execute the Loan Schedule which covers the Collateral financed hereunder, this Request for Advance shall operate as a loan and incorporates by reference all the terms and conditions of the Loan Agreement,
provided, however, Borrower shall, upon demand by Lender if Lender opts to so require, reimburse Lender in full for the Collateral Cost by paying to Lender the Balance Due Value of the Collateral equal to not less than 110% of the Collateral Cost
plus any unpaid Loan Payment or, at Lender’s option, Lender may declare an Event of Default and pursue its remedies under the Loan. 

Borrower confirms that the Collateral is insured with the Lender designated as Loss Payee/Additional Insured. 

Borrower confirms having made for its own records a copy of this Request for Advance contemporaneously with its
execution. This disclaimer of express and implied warranties has been discussed between the undersigned and Lender and has been specifically bargained for by the undersigned and Lender with respect to the loan of the Collateral particularly
described in the Loan. 
  

			
		  	AMYRIS BIOTECHNOLOGIES, INC.
		
		  	 By
                                         
                        

		
		  	 Title:
                                         
                    

		
		  	 Acceptance Date:
                                         
 

		
		  	 Advance Date:
                                         
     

  

 Exhibit B - Page 1 

 [EXHIBIT C] 

CERTIFIED COPY OF CORPORATION RESOLUTION 

AND INCUMBENCY CERTIFICATE 

of 

AMYRIS BIOTECHNOLOGIES, INC. 

“RESOLVED: That any one or more of the following officers of this corporation, 

 

									
	 Name
	  		  	 Title
	  		  	 Signature

					
	  
	  		  	  
	  		  	  

					
	  
	  		  	  
	  		  	  

be and they hereby are authorized and directed to from time to time enter into for and on behalf of this corporation personal property
loan agreements and other documents, instruments, and agreements in furtherance of such transactions, with this corporation as Borrower and ATEL VENTURES, INC. as Lender in such form and in such amounts and upon such terms as the officers of
this corporation or any one or more of them deem to be in the best interests of this corporation and its stockholders.” 

I,
                                , Secretary of AMYRIS BIOTECHNOLOGIES,
INC., hereby certifies that each person named above is an officer of                         , holding the office set
forth opposite his name and that the signature set forth opposite his name is his genuine signature. 
 I also hereby certify
that the foregoing is a true copy of a resolution duly and legally adopted by the Board of Directors of said corporation, on
                    , 20  . 
  

			
		  	     Dated

		
	 SEAL of Corporation
	  	
		
		  	 (Secretary)

  

 Exhibit C - Page 1 

 [EXHIBIT D] 

INSURANCE VERIFICATION 
  

									
	 TO:        
	  	  
	  		  	  
	  	
		  	 Insurance Company
	  		  	 Agent’s Name
	  	
					
		  	  
	  		  	  
	  	
		  	 Address
	  		  	
Phone Number                           
     
	  	
					
		  	  
	  		  		  	
		  	
City, State, Zip Code                        
    
	  		  		  	

 Gentlemen: 

The undersigned is presently leasing the following described Collateral: 

[Collateral Description] 

Under the term of our Loan Agreement, we hereby request that a Memorandum or Certificate of Insurance be issued as follows: 

1.            Liability Policy: “ATEL VENTURES, INC.
(ATEL) and ITS ASSIGNEES” to be named as an “ADDITIONAL INSURED” party. 

 [a]   Named Additional Insured: ATEL VENTURES, INC. and its Assignees 

 [b]   Minimum Insured Value: [$3,000,000] 

2.            Physical Damage or Loss Policy: “ATEL
and ITS ASSIGNEES” to be named as a “LOSS PAYEE” and 
  [a]   Loss Payee, as
interest may appear: ATEL VENTURES, INC. and its Assignees 
  [b]   Minimum Insured Value:
[$            ] 
 THIRTY (30) DAY NOTICE OF CANCELLATION OR CHANGE
IN POLICY MUST BE GIVEN 
 This insurance coverage is mandatory to consummate this loan transaction. Please mail one copy of
the Memorandum or Certificate of Insurance to ATEL and one to the additional insured/Loss Payee. 
 Your immediate
implementation of this instrument would be appreciated. Should you have any questions, please contact ATEL (415) 989-8800. 

The undersigned authorizes ATEL, its assignees, or the Loss Payee to coordinate insurance coverage requirement with our agents.

  

							
	 AMYRIS BIOTECHNOLOGIES, INC.
	 		  	 RETURN TO

ATEL VENTURES, INC.

600 California Street, 6th Floor

San Francisco, CA 94108-2733

	  
 By:
	 	  
	 		  
	  
 Title:
	 	  

 
	 		  
		 		 		  
	 Date:
	 	  
	 		  

  

 Exhibit D - Page 1 

 [EXHIBIT E] 

NOTICE AND ACKNOWLEDGMENT OF ASSIGNMENT 

Reference is hereby made to Master Loan and Security Agreement No. AMYRX, dated as of JUNE 1, 2010, and to Loan Schedule
No.          thereto, dated as of                     , between ATEL VENTURES, INC., as Lender
(“Lender”) and AMYRIS BIOTECHNOLOGIES, INC., as Borrower (“Borrower”) (the Loan Schedule and the Master Loan and Security Agreement as it is incorporated in the Loan Schedule, and any and all other documentation relating
to the transaction contemplated thereby is hereinafter referred to as the “Loan”.) 
 Lender hereby
gives Borrower notice and Borrower hereby acknowledges receipt of notice that Lender has assigned to                      whose offices are at
                                         
                    (“Assignee”) all of its rights, but none of its obligations, in the Loan and the Collateral financed thereunder
(“Collateral”) [as security for a loan made or about to be made by Assignee to Assignor]. Borrower agrees to make payment of any and all monies due or to become due Assignor thereunder to Assignee until Assignee instructs Borrower
otherwise in writing. 
 In recognition of Assignees reliance upon this Notice and Acknowledgment of Assignment
in agreeing make a loan secured by the Collateral subject to the Loan and in consideration of Assignee’s agreement to not interfere with Borrower’s quiet possession of the Collateral subject to the terms of the Loan, Borrower certifies,
confirms and agrees as follows: 

1.            That the Borrower will not assert against
Assignee any defense, claim, counterclaim, recoupment, setoff, or right to cancel or terminate the Loan which Borrower may have against Assignor. Borrower agrees that it will pay to Assignee all monies due or to become due under the Loan without
regard to any such defense, claim, counterclaim, recoupment, setoff or right whether arising under this Loan or any other transaction or otherwise and will not seek to recover any part of the same from Assignee, provided that Borrow shall not be
obligated to make any payment or perform any obligation under the Loan in favor of Assignee, if when no Event of Default shall have occurred and be continuing, Assignee interferes with Borrower’s right to quiet enjoyment of the Collateral.
[Notwithstanding the foregoing, nothing herein shall be deemed to relieve Assignor of any of its obligations to Borrower under the Loan.] 

2.            That the Collateral is in Borrower’s
possession at the address specified in the Loan Schedule, that the Collateral has been inspected by duly authorized representatives of Borrower and has been fully and finally accepted by duly authorized representatives of Borrower as the Collateral
under the Loan and found to be in good working order and suitable for the Borrower’s purposes in all respects. 

3.            That the Loan is in full force and effect and
that any modification, amendment or supplement to the Loan has been approved by Assignee. Any future modification, termination, amendment or supplement to the Loan or settlement of amounts due thereunder shall be ineffective without Assignee’s
prior written consent, which will not be unreasonably withheld or delayed. 

4.            That neither Borrower nor, to Borrower’s
knowledge, Assignor has breached the Loan in any respect and that payments of any and all monies due under the Loan have been and will continue to be paid in strict accordance with the terms of the Loan. As of
                , 2        , there are          successive loan
payments of $                 each due under the Loan. 

5.            [Borrower acknowledges that Assignee has not
assumed any of the obligations of Assignor or any other party under the terms of the Loan, and Assignee shall not be responsible in any way for the performance by Assignor or any other party of the terms and conditions of the Loan. Further,
]Assignor hereby notifies Borrower and Borrower acknowledges that Assignee is entitled to the benefits of each and every right accorded Assignor in the Loan, including but not limited to remedies, inspection rights, indemnity rights, right to give
consent, right to receive payment of costs and expenses incurred in exercising rights and remedies under the Loan, including reasonable attorney’s fees, and the right to receive notices and other documents required to be furnished under the
Loan. 
 6.            That Borrower has received no
notice of a prior sale, transfer, assignment, hypothecation or pledge of the Loan, the Loan Payment reserved thereunder or the Collateral. Borrower agrees to not enter into any assignment, sublease or other transfer of its rights, duties,
obligations or interests in the Loan or Collateral except in accordance with the provisions of the Loan. 

7.            That Borrower is aware of no claim of any kind
or nature in or to the Collateral, or of any lien thereon other than Assignor’s interest, Assignee’s [security] interest and Borrower’s rights thereto under the Loan, and that Borrower will keep the Loan and Collateral free and clear
of all liens and encumbrances arising by, through, or from Borrower. 

8.            Assignee hereby agrees to perform the
obligations set forth in Section 14 of the Master Loan and Security Agreement No. [COMPLETE]. 

9.            All representations and duties of Assignor
intended to induce Borrower to enter Into this Loan whether required by the Loan or otherwise, have been fulfilled. 
  

									
	LENDER AND ASSIGNOR:	    	BORROWER:	  	
	ATEL VENTURES, INC.	    	AMYRIS BIOTECHNOLOGIES, INC.	  	
					
	 By:
	 	  
	    	 By:
	 	  
	  	
					
	 Title:
	 	  
	    	 Title:
	 	  
	  	
					
	 Date:
	 	  
	    	 Date:
	 	  
	  	

  

 Exhibit E - Page 1 

			
	
	 ASSIGNEE:

		
	 By:
	 	  

		
	 Title:
	 	  

		
	 Date:
	 	  

 
  

 Exhibit E - Page 2 

 [EXHIBIT F] 

CONSENT TO REMOVAL OF PERSONAL PROPERTY 

The undersigned has an interest as owner in the following described real property, (the “Real Property”):

 That certain real property located at
                , in the County of                     , State
of                     . 

[INSERT BORROWER NAME], as Borrower (“Borrower”), in order to obtain a loan, has entered into or will enter
into Master Loan and Security Agreement No. [      ] dated as of                 , 2010 with ATEL VENTURES, INC., as Lender
(“Lender”). The Master Loan and Security Agreement and related Loan Schedules which incorporate the terms and conditions of the Master Loan and Security Agreement (together, the “Loans’), are secured by a lien on all personal
property and other assets of Borrower (the “Collateral”), which is or will be located upon the Real Property, and is described as follows: 

Various Personal Property of Borrower serving as collateral under the Loan and generally described as: 

See attached Exhibit “A” which Exhibit A may amended from time to time. 

Lender, as a condition to entering into the Loans, requires that the undersigned landlord consent to the removal by
Lender of the Personal Property from the Real Property, no matter how it is affixed thereto, and to the other matters set forth below. 

NOW, THEREFORE, for a good and sufficient consideration, receipt of which is hereby acknowledged, the undersigned
consents to the placing of the Personal Property on the Real Property, and agrees with Lender as follows: 

1.            The Personal Property shall be considered to be
personal property of Borrower and shall not be considered part of the Real Property regardless of whether or by what means it is or may become attached or affixed to the Real Property. 

2.            The undersigned has not and will not claim any
interest in the Personal Property. The undersigned waives any right of distraint, attachment or execution against the Personal Property or any claim to the Personal Property, statutory or otherwise, during the effectiveness of the Loans. 

3.            The undersigned will permit Lender or its
successors and assigns to enter upon the Real Property for the purpose of exercising any right it may have under the terms of the Loans or otherwise including, without limitation, the right to remove the Personal Property from the Real Property;
provided, however, that if Lender, in removing the Personal Property damages any improvements of the undersigned on the Real Property, Lender will at its expense, cause same to be promptly repaired. 

4.            This agreement shall be binding upon the heirs,
successors and assignees of the undersigned. 
 IN WITNESS WHEREOF, the undersigned has executed this instrument
as of                 , 2010. 
  

			
	  

		
	 By:
	 	
	 By:
	 	  

		
	 Title:
	 	  

Acknowledged and Agreed: 
  

					
	 ATEL VENTURES, INC.
	 	
			
	 By:
	 	  
	 	
			
	 Title:
	 	  
	 	

 The foregoing Consent must be returned to: 

ATEL Ventures, Inc. 

600 California Street, 6th Floor 

San Francisco, California 94108 

Ann: Kay Jones 
  

 Exhibit F - Page 1 

 EXHIBIT A TO 

CONSENT TO REMOVAL OF PERSONAL PROPERTY 
  

 Exhibit F - Page 2 

 [EXHIBIT G] 

WAIVER AGREEMENT 

                 (“Customer) and
                 (“Company’) entered into a [                ]
dated as of                  (“Agreement”) for the placement of certain Equipment, as defined below, at Company’s address at
                                         
                        (the “Location”). 

ATEL VENTURES, INC. (“ATEL”) has entered into a Master Loan and Security Agreement No.
[      ] with Customer dated as of
                                , (the “Loan Agreement”) covering the
equipment described on Exhibit “A” hereto and any additions, accessions or replacements thereto (the “Equipment). 

ATEL, Company and Customer now desire to enter into this Waiver Agreement (“Waiver) as of
                                . 

Notwithstanding anything to the contrary contained in this Waiver, Customer, Company and ATEL agree as follows: 

 

	1.	 Company shall have no right of bailment and Company shall not hold any or all of the Equipment in bailment. 

 

	2.	 The Equipment shall be considered to be personal property and shall not be considered pan of any real property regardless of whether or by what
means it is or may become attached or affixed to any real or other personal property. 

  

	3.	 Company has no, and will not claim any, interest in the Equipment. 

 

	4.	 Upon three days prior notice to Company, Company will permit ATEL to enter the Location for the purpose of removing the Equipment, provided that
ATEL indemnifies Company and holds it harmless from and against any other person, corporation or entity claiming to have any interest in the Equipment. Company agrees to such removal of the Equipment. If ATEL, in removing any of the Equipment
damages any improvements of Company at the Location, ATEL will cause the same to be repaired at ATEL’s expense. 

  

	5.	 Company shall not remove any of the Equipment without ATEL’s prior written consent. Company shall notify ATEL within 10 days of any termination
or expiration of the Agreement and permit ATEL to remove the Equipment as described in Section 4 above. 

  

	6.	 All notices hereunder shall be sent by reliable, overnight messenger, with proof of delivery. The terms of this Waiver shall be binding on the
heirs, successors and assigns of each party. Customer may not assign the Agreement without ATEL’s prior written consent. Company may assign the Agreement with prior written notice to ATEL. 

 

	7.	 Company and Customer shall not amend the Agreement without prior written notice to ATEL. 

 

	8.	 This Waiver may only be modified by a writing signed by an authorized representative of each party. 

 

	9.	 This Waiver may be executed in counterparts all of which together shall constitute the original. 

 

	11.	 In the event of any conflict between the terms of this Waiver and the Agreement the terms of this Waiver shall prevail.

  

	12.	 This Waiver shall be deemed to have been made under and shall be governed by the laws of the State of California in all respects, including matters
of construction, validity and performance. At ATEL’s sole discretion, option and election, jurisdiction and venue for any legal action between the parties arising out of or relating to this Waiver shall be in the Superior Court of San Francisco
County, California, or, in cases where federal diversity jurisdiction is available, in the United States District Court for the Northern District of California located in San Francisco, California. 

 

 Exhibit G - Page 1 

 IN WITNESS WHEREOF, the parties have executed this Waiver Agreement. 

 

											
	 Company:
	 		 		  	 Customer.
	 		  	
				
	  
	 		  	  
	  	
	 By:
	 		 		  	 By:
	 		  	
	 Title:
	 		 		  	 Title:
	 		  	
	 Notice Address:
	 	  
	 		  	 Notice Address:
	 	  
	  	
		 	  
	 		  		 	  
	  	

											
	 Attention:
	 		 		  	 Attention: ________________________________________
	  	
	 Telephone:
	 		 		  	 Telephone:
	 		  	
	 Fax:
	 		 		  	 Fax:
	 		  	

  
 ATEL VENTURES, INC.

 By: 

Title: 
 Notice
Address: 600 California Street, 6th Floor 
 San Francisco, CA 94108 

Attention: General Counsel 

Telephone: (415) 989-8800 

Fax: (415) 616-5555 
  

 Exhibit G - Page 2 

 [EXHIBIT H] 

BAILEE WAIVER AND AGREEMENT 

This Bailee Waiver and Agreement (this “Agreement”) is executed by the undersigned for the benefit of ATEL VENTURES, INC., as
Lender (the “Lender”) under the than Agreement defined below, effective as of             , 2010, as follows: 

DEFINITIONS 

The following definitions shall apply throughout this Agreement: 

“Lender” means ATEL VENTURES, INC., a California corporation with an office located at 600 California Street,
6th Floor, San Francisco, CA 94108, in its capacity as the Lender under the Loan Agreement and its successors and assigns. 

“Bailee” means the undersigned, and its successors and assigns. 

“Borrower” means [INSERT BORROWER NAME], a
                 corporation 

“Business Day” is any day that is not a Saturday, Sunday or a day on which banks are closed. 

“Collateral” has the meaning specified in the Loan Agreement (including, without limitation, Borrower’s
accounts, payment intangibles and inventory, and other assets of the Borrower related thereto). 

“Loan Agreement” means that certain Master Loan and Security Agreement No
[    ]     dated as of              , 2008, among the Borrower, the Lender, and any amendment restatement supplement or other
modification thereof 
 “Lender” means the Lender (as defined in the Loan Agreement) as a party to the
Loan Agreement. 
 “Premises” collectively means any and all locations owned, leased, or otherwise
controlled by the Bailee where any Property is located. 
 “Property’ means,
collectively, any and all property constituting Collateral (including, without limitation, inventory and books and records) now or hereafter owned by the Borrower and delivered by or on behalf of the Borrower to the Bailee pursuant to any bailment
agreement processing agreement, consignment “sale or return” or similar agreement (regardless of when, or whether, title passes to the Bailee) or any other agreement, which at any time, from time to time, is stored on or otherwise located
on the Premises for any purpose. “Property” also includes any and all proceeds of any of the foregoing, including, without limitation, all accounts, cash proceeds, or other property received upon sale or disposition thereof. 

RECITALS 

A.            The Borrower and the Lender have entered into
the Loan Agreement 
 B.            To secure the
payment and performance of the Borrower’s obligations under the Loan Agreement the Borrower has granted to the Lender pursuant to the Loan Agreement, a continuing security interest and lien in (among other property) the Property. 

C.            The Borrower has delivered, and from time to
time hereafter will deliver, to the Bailee the Property at the Premises. 

D.            In consideration of the Lender’s agreement
to provide credit to the Borrower under the Loan Agreement, the Lender has required that the Bailee enter into this Agreement with the Lender. 

NOW THEREFORE, for value received, and for other good and valuable consideration, the receipt and adequacy of which
hereby are acknowledged, the Bailee hereby agrees with the Lender, as follows: 

1.            Notification and Acknowledgement. The
Lender hereby notifies the Bailee often continuing security interest and lien of the Lender, in and to all of the Collateral, including all Property now or hereafter at any time in possession of the Bailee. The Bailee hereby acknowledges receipt of
such notification. The Bailee hereby acknowledges and agrees that title to all Property now or hereafter received from the Borrower and held by the Bailee for processing, storing, or sale shall at all times remain with the Borrower, and the Bailee
shall make no claim with respect thereto. The Bailee agrees, at the Borrower’s expense, to execute in favor of the Lender, or join with the Borrower in the execution of such documents, instruments, financing statements, certificates, and
agreements as the Lender may reasonably request from the Bailee hereafter to evidence or give notice of such security interest. 
  

 Exhibit H - Page 1 

2.            Waiver. The Bailee hereby waives and
releases any and all liens, security interests, or other interests, however arising, which the Bailee now has or may hereafter acquire with respect to any of the Property, and agrees that all possessory rights now or hereafter claimed by the Bailee
with respect thereto are expressly subordinate and subject to the Lender’s rights as provided herein. 

3.            Directives. Until receipt of further
smitten notice from the Lender to the Bailee at the Bailee’s address set forth in paragraph 10 (“Notices”) below, the Bailee is hereby authorized to release Property in accordance with the Borrower’s directions, provided, that
upon written notice by the Lender to the Bailee, the Bailee shall not honor any directions by the Borrower and shall release Property only in accordance with the Lender’s instructions. 

4.            Rights of the Lender. The Bailee agrees
that the Lender, through its authorized representatives, may enter upon the Premises from time to time for the purpose of inspecting, repairing, removing, or conducting a sale or sales of any or all of the Property, and the Bailee shall not hinder
or prevent the Lender from taking any such action. The Bailee further agrees that the Lender shall have no obligation or liability to the Bailee except for costs and expenses actually incurred by the Bailee to repair any damage to the Premises
directly caused by the Lender or its authorized representatives in any such removal of the Property. 

5.            Segregation. The Bailee hereby agrees
that the Property at all times will be kept segregated and apart from other property, if any, from time to time located on the Premises. 

6.            Access; Charges. Nothing contained in
this agreement shall modify the obligation of the Borrower to pay charges and fees of the Bailee. The Bailee agrees to promptly notify the Lender if at any time any charges or fees owing from the Borrower become ninety (90) days past due. The
Bailee agrees that upon receipt of such notice the Lender, at its option, may (a) maintain the Property at the Premises for a period of up to ninety (90) days, without charge other than reasonable and customary storage fees and charges
accruing during such ninety (90) day period as may be mutually agreed to between the Bailee and the Lender, (b) enter the Premises during the Bailee’s normal business hours, upon notice to the Bailee (or at such other mutually
agreeable time as may be determined by the Lender and the Bailee) in order to remove the Property therefrom, without charge, other than accrued processing charges with respect to Property removed from the Premises by the Lender, and/or
(c) require the Bailee to process or complete processing of any Property then or thereafter delivered to the Bailee, at a price mutually agreed to by the Lender and the Bailee. In any such event, the Bailee agrees to cooperate with the Lender
and not to hinder the Lender’s actions in enforcing its remedies with respect to the Property or any other Collateral (as defined in the Loan Agreement). 

7.            Delivery of Proceeds to the Lender and the
Lenders. If from time to time the Bailee ever comes into possession or control of any identifiable cash proceeds arising from the sale of any of the Property, such proceeds shall be held by the Bailee in trust for the benefit of the Lender, and
the sane shall be paid and delivered to the Lender promptly after receipt by the Bailee. 

8.            Notice of Default; Notice of
Termination. Prior to the Bailee’s taking any action to terminate the agreements between the Bailee and the Borrower (the “Underlying Agreements”) or to remove the Property (other than in accordance with the instructions of the
Borrower in the ordinary course of business prior to the Bailee’s receipt of a Notice) for breach of or default under any Underlying Agreement, the Bailee shall give the Lender not less than thirty (30) days’ written notice of such
action at the address set forth below, and a reasonable opportunity to preserve, protect, liquidate, or remove any Collateral from the Premises (but in no event to exceed the time period set forth in paragraph 6 hereof) and, if the Lender so elects,
to cure such breach of or default under the Underlying Agreements. Notwithstanding the provisions of this paragraph, the Lender shall have no obligation to cure any such breach or default. The cure of any such breach or default by the Lender on any
one occasion shall not obligate the Lender to cure any other breach or default or to cure such breach or default on any other occasion. 

9.            Reliance by the Lender. This Agreement
is for the benefit of the Lender. 

10.          Notices. All notices, consents, requests,
approvals, demands, or other communication by any party to this Agreement must be in writing and shall be deemed to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after
deposit in the U.S. mail, first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission, when sent by electronic mail or facsimile transmission; (e) one (1) Business Day after
deposit with a reputable overnight courier with all charges prepaid: or (d) when delivered, if hand-delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address, facsimile number, or email address
indicated below. 
  

					
		 	 Lender:
	    	 ATEL VENTURES, INC.

		 		    	 600 Califomia Street, 6th. Floor

		 		    	 San Francisco, CA 94108

		 		    	 Attention: Kay B. Jones

		 		    	 Fax: (415) 616-5555

		 		    	 E-Mail: kjones@atel.com

  

 

 Exhibit H - Page 2 

					
		  	 Bailce:
	    	 [INSERT BAILEE NAME]

		  		    	
[                           
                    ]

		  		    	
[                           
                    ]

		  		    	 Attention:
                        

		  		    	 Fax:
                                 

		  		    	 E-Mail:
                            

			
		  	 Borrower
	    	 [INSERT BORROWER NAME]

		  		    	
[                           
                    ]

		  		    	
[                           
                    ]

		  		    	 Attention:
                        

		  		    	 Fax:
                                 

		  		    	 E-Mail:
                            

Any party hereto shall have the right to change its address for notice hereunder to any other location within the continental United
States by notice to the other parties hereto of such new address at least thirty (30) days prior to the effective date of such new address. 

11.            Governing Law.  THIS
AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. THIS AGREEMENT SHALL BE BINDING UPON THE BAILEE AND ITS SUCCESSORS AND ASSIGNS AND INURE TO THE
BENEFIT OF THE LENDER AND ITS SUCCESSORS AND ASSIGNS. 
 [signature pages follow] 

 

 Exhibit H - Page 3 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement
as of the date above fast written. 
  

			
	
[                            ],
as Bailee

	 By:
                                         
                        

	 Name:
	 	
                             
                          

	 Title:
	 	
                             
                          

	
	 ATEL VENTURES, INC., as Lender

	 By:
                                         
                        

	 Name:
	 	
                             
                          

	 Title:
	 	
                             
                          

	
	
[                            ],
as Borrower

	
	 By:
                                         
                        

	 Name:
	 	
                             
                          

	 Title:
	 	
                             
                          

 

 Exhibit H - Page 4Employment Agreement

 Exhibit 10.3 

EXECUTION COPY 

EMPLOYMENT AGREEMENT 

This Employment Agreement (the “Agreement”), is effective as of August 1, 2010 (the “Effective Date”), and executed
August 12, 2010, between Ampio Pharmaceuticals, Inc., a Delaware corporation headquartered at 8400 East Crescent Parkway, Suite 600, Greenwood Village, CO 80111 USA, hereinafter referred to as the “Company”), and Donald B. Wingerter,
Jr. “Employee”). 
 RECITALS 

WHEREAS, the Company is a duly organized Delaware corporation, with its principal place of business within the State of Colorado,
and is in the business of developing and marketing pharmaceutical products; and 
 WHEREAS, the Company desires assurance
of the continued association and services of the Employee in order to continue to retain the Employee’s experience, skills, abilities, background and knowledge, and is willing to continue to engage the Employee’s services on the terms and
conditions set forth in this Agreement; and 
 WHEREAS, Employee desires to be in the continued employ of the Company,
and is willing to accept such continued employment on the terms and conditions set forth in this Agreement. 
 NOW, THEREFORE, the
parties hereto agree to the terms and conditions of this Agreement as follows: 
 1. Employment for Term. The Company hereby agrees to
employ Employee and Employee hereby accepts such employment with the Company for the period of 36 months beginning on the Effective Date. The term of this Agreement (the “Term”) shall continue until the termination of Employee’s
employment in accordance with the provisions of this Agreement. The termination of Employee’s employment under this Agreement shall end the Term but shall not terminate Employee’s or the Company’s other obligations that are intended
to survive the termination of this Agreement (including without limitation, the payments under Section 7 and 8 and Employee’s obligations under Section 9). 

2. Position and Duties. During the Term, Employee shall serve as Chief Executive Officer and a Director of the Company, perform such duties as are
consistent with his position and report to the Board of Directors of the Company. During the Term, Employee shall also hold such additional positions and titles as the Board of Directors of the Company (the “Board”) may determine from time
to time. During the Term, Employee shall devote as much time as is necessary to satisfactorily perform his duties as the Chief Executive Officer of the Company. Without limitation of the foregoing, the Company hereby acknowledges that it consents to
Employee’s participation in those outside activities described on Exhibit A hereto. Employee may engage in any civic and not-for-profit activities so long as such activities do not materially interfere with the performance of his duties
hereunder or present a conflict of interest with the Company. During the Term of this Agreement, Employee agrees not to acquire, assume or participate in, directly or indirectly, any position, investment or interest known by the Employee to be
adverse or antagonistic to the Company, its business or prospects, its financial position, or otherwise or in any company, person or entity that is, directly or indirectly, in competition with the business of the Company or any of its affiliates.

  

 1 

 The Company shall nominate Employee, and use its best efforts to have Employee elected, to the Board of
Directors of the Company (the “Board”) throughout the Term of this Agreement and, subject to the fiduciary duties of the Board and the Nominating Committee to act in the best interests of the stockholders, shall include him in the
management slate for election as a director at every stockholders meeting during the Term at which his term as a director would otherwise expire. Employee agrees to accept election, and to serve during the Term, as director of the Company. On
termination of Employee’s employment, regardless of the reason for such termination, Employee shall immediately (and with contemporaneous effect) resign any directorships, offices or other positions that Employee may hold in the Company or any
affiliate, unless otherwise agreed in writing by the parties. 
 3. Compensation. 

(a) Base Salary. The Company shall pay Employee a base salary of $145,000 per annum, payable at least monthly on the Company’s
regular pay cycle for professional employees (the “Base Salary”). At such time as the Company receives additional funding in the amount of $10 million or more following the execution hereof, the Base Salary shall automatically increase,
without additional action by the Compensation Committee or Board, to $275,000 per annum, payable as described above. Except as specifically otherwise provided herein, the Base Salary may be increased only by recommendation of the Compensation
Committee of the Board and ratified by the Compensation Committee or a majority of the independent members of the Board. 

(b) Annual Review. The Base Salary shall be reviewed at the end of each calendar year (the first such review to occur at the end
of calendar year 2010). 
 (c) Equity Compensation. In connection with the execution of this Agreement, the Company
hereby agrees to grant initial equity compensation to Employee in the aggregate amount of 675,000 options to purchase shares of Company Common Stock. These options shall vest in accordance with the terms and schedule set forth in Exhibit B hereto.
Such vesting schedule will be accelerated, to the extent provided in Section 8 of this agreement. 
 (d) Other and
Additional Compensation. Subsections (a) and (c) above establish Employee’s compensation during the Term which shall not preclude the Board from awarding Employee a higher salary or any bonuses or stock options, restricted stock
or other forms of additional equity awards in the discretion of the Board during the Term at any time. The Employee shall be eligible for an annual discretionary bonus (hereinafter referred to as the “Bonus”) with a target amount of fifty
percent (50%) of the Base Salary, subject to standard deductions and withholdings, based on the Compensation Committee’s determination, in good faith, and based upon the Employee’s individual achievement and company performance
objectives as set by the Board or the Compensation Committee, of whether the Employee has met such performance milestones as are established for the Employee by the Board or the Compensation Committee, in good faith, in consultation with the
Employee (hereinafter referred to as the “Performance Milestones”). The Performance Milestones will be based on certain factors including, but not limited to, the Employee’s performance and the Company’s financial performance.
The Employee’s Bonus target will be reviewed annually and may be adjusted by the Board or the Compensation Committee in its discretion, provided however, that the Bonus target may only be reduced upon Employee’s written consent. The
Employee must be employed on the date the Bonus is awarded to be eligible for the Bonus, subject to the termination provisions hereof. Bonuses shall be paid during the calendar quarter following the calendar quarter for which such Bonus was earned
when Performance Milestones are met during a calendar quarter. Fourth quarter Bonuses and Bonuses calculated on the basis of partial Performance Milestone satisfaction shall be paid within 120 days of fiscal year-end. 

 

 2 

 4. Employee Benefits. During the Term, Employee shall be entitled to participate at the same level as
other senior executive officers of the Company in any group insurance, hospitalization, medical, health and accident, disability, fringe benefit and tax-qualified retirement plans or programs of the Company now existing or hereafter established to
the extent that he is eligible under the general provisions thereof. For the term of this Agreement, Employee shall be entitled to paid vacation at the rate of (4) weeks per annum. In accordance with Company policy, unused vacation may not be
carried over from year to year. 
 5. Expenses. The Company shall reimburse Employee for actual, reasonable out-of-pocket expenses
incurred by him in the performance of his services for the Company upon the receipt of appropriate documentation of such expenses which shall be submitted in such form, and with such supporting documentation, as called for or required by Company
policy. 
 6. Termination. 

(a) General. The Term shall end immediately upon Employee’s death. Employee’s employment may also be terminated by the
Company with or without Cause or as a result of Employee’s Disability, as defined in Section 7 or by Employee with or without Good Reason (as such terms are defined below). 

(b) Notice of Termination. Either party shall give written notice of termination to the other party. 

(c) Notification of New Employer. In the event that Employee leaves the employ of the Company, Employee grants consent to
notification by the Company to Employee’s new employer about his rights and obligations under this Agreement and the PIA (hereinafter defined). 

7. Severance Benefits. 

(a) Cause Defined. “Cause” means (i) willful malfeasance or willful misconduct by Employee in connection with his
employment; (ii) Employee’s gross negligence in performing any of his duties under this Agreement; (iii) Employee’s conviction of, or entry of a plea of guilty to, or entry of a plea of nolo contendre with respect to, any
crime other than a traffic violation or infraction which is a misdemeanor; (iv) Employee’s willful and deliberate violation of a Company policy, (v) Employee’s unintended but material breach of any written policy applicable to
all employees adopted by the Company which is not cured to the reasonable satisfaction of the Board of Directors within thirty (30) business days after notice thereof; (vi) the Employee’s unauthorized use or disclosure of any
proprietary information or trade secrets of the Company or any other party as to which the Employee owes an obligation of nondisclosure as a result of the Employee’s relationship with the Company, (vii) the Employee’s willful and
deliberate breach of his obligations under this Agreement, or (viii) any other material breach by Employee of any of his obligations in this Agreement which is not cured to the reasonable satisfaction of the Board of Directors within thirty
(30) business days after notice thereof. 
  

 3 

 (b) Disability Defined. “Disability” shall mean (i) Employee’s
incapacity due to a physical or mental condition and, if reasonable accommodation is required by law, after any reasonable accommodation, that results in Employee being substantially unable to perform his duties hereunder for six consecutive months
(or for six months out of any nine month period) or (ii) a qualified independent physician mutually acceptable to the Company and Employee determines that Employee is incapacitated due to a physical or mental condition and, if reasonable
accommodation is required by law, after any reasonable accommodation so as to be unable to regularly perform the duties of his position and such condition is expected to be of a permanent or near-permanent duration. Until such time as Employee is
terminated for Disability under this paragraph (b), Employee shall continue to receive his Base Salary hereunder, provided that if the Company provides Employee with disability insurance coverage, payments of Employee’s Base Salary shall be
reduced by the amount of any disability insurance payments received by Employee due to such coverage. The Company shall give Employee written notice of termination due to Disability which shall take effect sixty (60) days after the date it is
sent to Employee unless Employee shall have returned to the performance of his duties hereunder during such sixty (60) day period (whereupon such notice shall become void). In the event that the Company terminates Employee’s employment as
a result of his Disability, Employee shall be entitled to the same benefits as if his employment had been terminated by the Company without Cause. 

(c) Good Reason Defined. For purposes of this Agreement, “Good Reason” shall mean, without Employee’s written
consent: (i) there is a material reduction of the level of Employee’s compensation (excluding any bonuses) (except where there is a general reduction applicable to the management team generally, provided, however, that in no case may the
Base Salary be reduced below the amount stated in Section 3(a)), (ii) there is a material reduction in Employee’s overall responsibilities or authority, or scope of duties (it being understood that the occurrence of a Change in
Control shall not, by itself, necessarily constitute a reduction in Employee’s responsibilities or authority); or (iii) there is a material change in the principal geographic location at which Employee must perform his services (it being
understood that the relocation of Employee to a facility or a location within forty (40) miles of the State Capitol Building in Denver, Colorado shall not be deemed material for purposes of this Agreement). No event shall be deemed to be
“Good Reason” if the Company has cured the event (if susceptible to cure) within 30 days of receipt of written notice from Employee specifying the event or events which, absent cure, would constitute “Good Cause.” 

(d) Accrued Compensation Defined. Accrued Compensation shall mean an amount which shall include all amounts earned or accrued by
Employee through the date of termination of this Agreement but not paid as of such date, including (i) Base Salary, (ii) reimbursement for business expenses incurred by the Employee on behalf of the Company, pursuant to the Company’s
expense reimbursement policy in effect at such time, (iii) any expense allowance pursuant to Company policy, (iv) accrued but unused vacation pay per Company policy, and (v) bonuses and incentive compensation earned and awarded prior
to the date of termination. Accrued Compensation shall be paid on the first regular pay date after the date of termination (or earlier, if required by applicable law). 

(e) Termination. 

(i) Cause; Without Good Reason; Death. If the Company ends the Term for Cause, if Employee resigns as an employee
of the Company for reasons other than an event of Good Reason, or the Employee dies, then the Company shall pay to Employee the Accrued Compensation but shall have no obligation to pay Employee any amount, whether for salary, benefits, bonuses, or
other compensation or expense reimbursements of any kind, accruing after the end of the Term, and such rights shall, except as otherwise required by law or pursuant to the applicable award agreement or plan, be forfeited immediately upon the end of
the Term. For the sake of clarity, any stock options, restricted stock or other equity compensation shall, to the extent vested on the date of resignation without Good Reason, the date the Company ends the Term for Cause, or the date of
Employee’s death, remain outstanding and exercisable to the extent provided in the applicable award agreement or plan, by the Employee or his personal representative or executor. 

 

 4 

 (ii) Without Cause; Good Reason. In the event that the Company terminates
Employee’s employment hereunder without Cause, Employee terminates his employment with Good Reason, he shall be entitled to the Accrued Compensation and, subject to Section 21 and 22 below, 

(A) A lump sum payment equal to two times his Base Salary in effect at the date of termination, less applicable withholding. 

(B) Continued participation (via state or federal insurance continuation laws such as COBRA, to the extent available) in the health and
welfare plans (or comparable plans, if continued participation in the Company’s plans is not available) provided by the Company to Employee at the time of termination for a period of two years from the date of termination or, if earlier, until
he is eligible for comparable coverage with a subsequent employer. The Company agrees to reimburse the payments Employee makes for such coverage, whether via continuation or separate comparable policy. Premium reimbursements shall be made by the
Company to Employee consistent with the Company’s normal expense reimbursement policy, provided that Employee submits documentation to the Company substantiating his payments for insurance coverage. Employee shall give the Company prompt notice
of his eligibility for comparable coverage. 
 (C) All vested stock options shall remain exercisable from the
date of termination until the expiration date of the applicable award. So long as the Section 8 below does not apply, then all options which are unvested at the date of termination Without Cause or for Good Reason shall be accelerated as
of the date of termination such that the number of option shares equal to
1/36th the number of option shares multiplied by the
number of full months of Employee’s employment hereunder shall be deemed vested and immediately exercisable by the Employee. Any unvested options over and above the foregoing shall be cancelled and of no further force or effect, and shall not
be exercisable by the Employee. 
 (D) Any severance payments and/or other separation benefits contemplated by this Agreement are
conditional on Employee: (i) continuing to comply with the terms of this Agreement and the PIA (as defined herein); (ii) delivering prior to or contemporaneously with any such severance payments, and not revoking, (x) a customary
general release of claims relating to Employee’s employment and/or this Agreement against the Company or its successor, its subsidiaries and their respective directors, officers and stockholders and (y) a customary affirmation of
Employee’s continuing obligations hereunder and under the PIA. 
  

 5 

 Unless otherwise required by law, no severance payments and/or benefits under this Agreement will be paid
and/or provided until after the expiration of any relevant revocation period. 
 8. Change in Control Payments. The provisions of this
paragraph 8 set forth the terms of an agreement reached between Employee and the Company regarding Employee’s rights and obligations upon the occurrence of a “Change in Control” (as hereinafter defined) of the Company during the Term.
These provisions are intended to assure and encourage in advance Employee’s continued attention and dedication to his assigned duties and his objectivity during the pendency and after the occurrence of any such Change in Control. The following
provisions shall apply in the event of a Change in Control, in addition to any payment or benefit that may be required pursuant to Section 7. 

(a) Equity. Upon the occurrence of a Change in Control, all stock options, restricted stock and other stock-based grants to
Employee by the Company or that may be granted in the future shall, irrespective of any provisions of his award agreements, immediately and irrevocably vest and become exercisable and any restrictions thereon shall lapse. All stock options shall
remain exercisable from the date of the Change in Control until the expiration of the term of such stock options. 
 (b)
Definitions. For purposes of this paragraph 8, the following terms shall have the following meanings: 
 “Change in Control” shall
mean any of the following: 
 (1) the acquisition by any individual, entity, or group (within the meaning of
Section 13(d)(3) or 14(d)(2) of the Exchange Act) (the “Acquiring Person”), other than the Company, or any of its Subsidiaries, of beneficial ownership (within the meaning of Rule 13d-3- promulgated under the Exchange Act) of 50% or
more of the combined voting power or economic interests of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (excluding any issuance of securities by the Company in a transaction or series
of transactions made principally for bona fide equity financing purposes, and any issuance of Company securities in connection with the proposed acquisition of DMI BioSciences, Inc.; or 

(2) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company
is party (including, without limitation, any stock acquisition, reorganization, merger or consolidation but excluding any issuance of securities by the Company in a transaction or series of transactions made principally for bona fide equity
financing purposes, and also excluding the issuance of Company securities in connection with the acquisition of DMI BioSciences, Inc.) other than a transaction or series of related transactions in which the holders of the voting securities of the
Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or series of related transactions, as a result of shares in the Company held by such holders prior to such
transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity (or if the Company or such other surviving or
resulting entity is a wholly-owned subsidiary immediately following such acquisition, its parent); or 
 (3) the sale or other
disposition of all or substantially all of the assets of the Company in one transaction or series of related transactions. 
  

 6 

 9. Proprietary Information and Inventions Agreement. As a condition of Employee’s employment
with the Company, Employee agrees to sign the Company’s standard form of Proprietary Information and Inventions Agreement (“PIA”). 

10. Successors and Assigns. 

(a) Employee. This Agreement is a personal contract, and the rights and interests that the Agreement accords to Employee may not be
sold, transferred, assigned, pledged, encumbered, or hypothecated by him. All rights and benefits of Employee shall be for the sole personal benefit of Employee, and no other person shall acquire any right, title or interest under this Agreement by
reason of any sale, assignment, transfer, claim or judgment or bankruptcy proceedings against Employee. Except as so provided, this Agreement shall inure to the benefit of and be binding upon Employee and his personal representatives, distributees
and legatees. 
 (b) The Company. This Agreement shall be binding upon the Company and inure to the benefit of the
Company and of its successors and assigns, including (but not limited to) any Company that may acquire all or substantially all of the Company’s assets or business or into or with which the Company may be consolidated or merged. Any such
successor of the Company will be deemed substituted for the Company under the terms of this Agreement for all purposes. For this purpose, “successor” means any person, firm, corporation or other business entity which at any time, whether
by purchase, merger or otherwise, directly or indirectly acquires all or substantially all of the assets or business of the Company. 
 11.
Entire Agreement. This Agreement (together with the equity award agreements referred to herein) represents the entire agreement between the parties concerning Employee’s employment with the Company and supersedes all prior negotiations,
discussions, understanding and agreements, whether written or oral, between Employee and the Company relating to the subject matter of this Agreement. 

12. Amendment or Modification, Waiver. No provision of this Agreement may be amended or waived unless such amendment or waiver is agreed to in
writing signed by Employee and by a duly authorized officer of the Company. No waiver by any party to this Agreement or any breach by another party of any condition or provision of this Agreement to be performed by such other party shall be deemed a
waiver of a similar or dissimilar condition or provision at the same time, any prior time or any subsequent time. 
 13. Notices. Any
notice to be given under this Agreement shall be in writing and delivered personally or sent by overnight courier or registered or certified mail, postage prepaid, return receipt requested, addressed to the party concerned at the address indicated
below, or to such other address of which such party subsequently may give notice in writing: 
  

			
	 If to Employee:
	  	To the address specified in the payroll records of the Company.
		
	 If to the Company:
	  	 Ampio Pharmaceuticals, Inc.

8400 East Crescent Parkway
 Suite
600
 Greenwood Village, Colorado 80111

  

 7 

 Any notice delivered personally or by overnight courier shall be deemed given on the date delivered and any
notice sent by registered or certified mail, postage prepaid, return receipt requested, shall be deemed given on the date mailed. 
 14.
Severability. If any provision of this Agreement or the application of any such provision to any party or circumstances shall be determined by any court of competent jurisdiction or arbitrator acting pursuant to Section 19 below to be
invalid and unenforceable to any extent, the remainder of this Agreement or the application of such provision to such person or circumstances other than those to which it is so determined to be invalid and unenforceable shall not be affected, and
each provision of this Agreement shall be validated and shall be enforced to the fullest extent permitted by law. If for any reason any provision of this Agreement containing restrictions is held to cover an area or to be for a length of time that
is unreasonable or in any other way is construed to be too broad or to any extent invalid, such provision shall not be determined to be entirely null, void and of no effect; instead, it is the intention and desire of both the Company and Employee
that, to the extent that the provision is or would be valid or enforceable under applicable law, any court of competent jurisdiction or arbitrator acting pursuant to Section 19 below shall construe and interpret or reform this Agreement to
provide for a restriction having the maximum enforceable area, time period and such other constraints or conditions (although not greater than those contained currently contained in this Agreement) as shall be valid and enforceable under the
applicable law. 
 15. Survivorship. The respective rights and obligations of the parties hereunder shall survive any termination of this
Agreement to the extent necessary to the intended preservation of such rights and obligations. 
 16. Headings. All descriptive headings
of sections and paragraphs in this Agreement are intended solely for convenience of reference, and no provision of this Agreement is to be construed by reference to the heading of any section or paragraph. 

17. Withholding Taxes. All salary, benefits, reimbursements and any other payments to Employee under this Agreement shall be subject to all
applicable payroll and withholding taxes and deductions required by any law, rule or regulation of and federal, state or local authority. 

18. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which
together constitute one and same instrument. The parties agree that facsimile signatures shall have the same force and effect as original signatures. 

19. Applicable Law; Arbitration. The validity, interpretation and enforcement of this Agreement and any amendments or modifications hereto shall
be governed by the laws of the State of Colorado, as applied to a contract executed within and to be performed in such State. The parties agree that any disputes shall be definitively resolved by binding arbitration before the American Arbitration
Association in Denver, Colorado in accordance with its rules of arbitration procedure then in effect. The parties consent to the jurisdiction to the federal courts of the District of Colorado or, if there shall be no jurisdiction, to the state
courts located in Arapahoe County, Colorado, to enforce any arbitration award rendered with respect thereto. Each party shall choose one arbitrator and the two arbitrators shall choose a third arbitrator. All costs and fees related to such
arbitration (and judicial enforcement proceedings, if any) shall be borne by the Company unless Employee’s claim is deemed to be frivolous by the arbitrator(s) or judge. 

 

 8 

 20. Legal Fees. The Company shall pay the reasonable expenses of Employee’s counsel in
negotiating this Agreement. 
 21. Section 409A. Notwithstanding anything to the contrary in this Agreement, if Employee is a
“specified employee” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the final regulations and any guidance promulgated thereunder (“Section 409A”) at the time
of Employee’s termination (other than due to death), and the severance payable to Employee, if any, pursuant to this Agreement, when considered together with any other severance payments or separation benefits which may be considered deferred
compensation under Section 409A (together, the “Deferred Compensation Separation Benefits”) will not and could not under any circumstances, regardless of when such termination occurs, be paid in full by March 15 of the year
following Employee’s termination, then only that portion of the Deferred Compensation Separation Benefits which do not exceed the Section 409A Limit (as defined below) may be made within the first six (6) months following
Employee’s termination of employment in accordance with the payment schedule applicable to each payment or benefit. For these purposes, each severance payment is hereby designated as a separate payment and will not collectively be treated as a
single payment. Any portion of the Deferred Compensation Separation Benefits in excess of the Section 409A Limit shall accrue and, to the extent such portion of the Deferred Compensation Separation Benefits would otherwise have been payable
within the first six (6) months following Employee’s termination of employment, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Employee’s
termination. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Employee dies following
his termination but prior to the six (6) month anniversary of his termination, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Employee’s
death and all other Deferred Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit. The foregoing provision is intended to comply with the requirements of Section 409A so
that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Company and Employee agree to work
together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Employee
under Section 409A. For purposes of this Agreement, “Section 409A Limit” will mean the lesser of two (2) times: (A) Employee’s annualized compensation based upon the annual rate of pay paid to Employee during the
Company’s taxable year preceding the Company’s taxable year of Employee’s termination of employment as determined under Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect
thereto; or (B) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Employee’s employment is terminated. 

22. Application of Internal Revenue Code Section 280G. If any payment or benefit Employee would receive pursuant to a Change in Control from
the Company or otherwise (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by
Section 4999 of the Code (the “Excise Tax”), then such Payment shall be equal to the Reduced Amount. The “Reduced Amount” shall be either (x) the largest portion of the Payment that would result in no portion of
the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the
Excise Tax (all computed at the highest applicable marginal rate), results in Employee’s receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.
If a reduction in payments or benefits constituting “parachute payments” is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the manner that results in the greatest economic benefit for Employee. If more
than one method of reduction will result in the same economic benefit, the items so reduced will be reduced pro rata. 
  

 9 

 In the event it is subsequently determined by the Internal Revenue Service that some portion of the Reduced
Amount as determined pursuant to clause (x) in the preceding paragraph is subject to the Excise Tax, Employee agrees to promptly return to the Company a sufficient amount of the Payment so that no portion of the Reduced Amount is subject to the
Excise Tax. For the avoidance of doubt, if the Reduced Amount is determined pursuant to clause (y) in the preceding paragraph, Employee will have no obligation to return any portion of the Payment pursuant to the preceding sentence. 

Unless Employee and the Company agree on an alternative accounting firm, the accounting firm engaged by the Company for general tax compliance purposes
as of the day prior to the effective date of the Change in Control shall perform the foregoing calculations. If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the
Change in Control, the Company shall appoint a nationally recognized accounting firm to make the determinations required hereunder. The Company shall bear all expenses with respect to the determinations by such accounting firm required to be made
hereunder. 
 The Company shall use commercially reasonable efforts to cause the accounting firm engaged to make the determinations hereunder to
provide its calculations, together with detailed supporting documentation, to the Employee and the Company within fifteen (15) calendar days after the date on which Employee’s right to a Payment is triggered (if requested at that time by
the Employee or the Company) or such other time as requested by Employee or the Company. 
 23. Indemnification. As a condition to the
effectiveness of this Agreement, the Company and Employee shall enter into a mutually acceptable indemnification agreement. 
 IN WITNESS
WHEREOF, the parties hereto have executed this Agreement as of the date first written above. 
  

									
	 AMPIO PHARMACEUTICALS, INC.
	  		 	EMPLOYEE
					
	By:	  	 /s/ Philip H. Coelho
	  		 		 	 /s/ Donald B. Wingerter, Jr.

	Name:	  	PHILIP H. COELHO	  		 	Name:	 	DONALD B. WINGERTER, JR.
		  	Chairman, Compensation Committee	  		 		 	
		  	Board of Directors	  		 		 	

  

 10 

 EXHIBIT A 

Outside Activities 
  

	 	1.	Serve on the Board of Directors of no more than two private or public companies whose business is not competitive with that of Ampio Pharmaceuticals, Inc. 

  

	 	2.	Serve as a consultant no more than one private or public company whose business is not competitive with that of Ampio Pharmaceuticals, Inc. 

Note: Neither of the possible outside activities may interfere with employee’s best efforts in meeting the responsibilities of CEO of Ampio
Pharmaceuticals, Inc. 
  

 11 

 EXHIBIT B 

Terms of Compensation 

Management equity grant: 
  

	 	•	 	 675,000 total options to purchase shares of the company’s common stock. The strike price for all options will be the last sale price of the
Company’s common stock as reported on Nasdaq.com on August 11, 2010. 

  

	 	•	 	 All options fully vest upon change in control, death, disability, termination without cause, termination for good reason 

 

	 	•	 	 225,000 options are fully vested on Day 1 of this agreement 

 

	 	•	 	 225,000 options vest 365 days thereafter 

  

	 	•	 	 225,000 options vest 730 days thereafter 

Management milestones that affect cash bonuses 
  

	 	1.	Obtaining $10 million in financing for the company 

  

	 	2.	Obtaining a successful phase 2 clinical trial for the diabetic retinopathy drug 

 

	 	3.	Preparing a fiscal budget, obtaining Board approval for that budget and meeting the spending limitations of that budget except for those extra budgetary expenditures
approved by the Board. 

  

	 	4.	Launching a second clinical trial for a drug at an expense approved by the Board 

 

	 	5.	Selling any of the Company IP at prices, and at times, approved by the Board 

  

 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]